<SEC-DOCUMENT>0001683168-25-000095.txt : 20250106
<SEC-HEADER>0001683168-25-000095.hdr.sgml : 20250106
<ACCEPTANCE-DATETIME>20250106060116
ACCESSION NUMBER:		0001683168-25-000095
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20250106
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250106
DATE AS OF CHANGE:		20250106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INSEEGO CORP.
		CENTRAL INDEX KEY:			0001022652
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMUNICATIONS EQUIPMENT, NEC [3669]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				813377646
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38358
		FILM NUMBER:		25508914

	BUSINESS ADDRESS:	
		STREET 1:		9710 SCRANTON ROAD
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		8588123400

	MAIL ADDRESS:	
		STREET 1:		9710 SCRANTON ROAD
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NOVATEL WIRELESS INC
		DATE OF NAME CHANGE:	20000726
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>inseego_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:INSG="http://inseego.com/20250106">
<head>
     <title>Inseego Corp Form 8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_03F_INSG_inseego.com_20250106 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20250106_20250106 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001022652 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-01-06" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-01-06" id="Fact000004" name="dei:EntityCentralIndexKey">0001022652</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="insg-20250106.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-01-06">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022652</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-06</xbrli:startDate>
        <xbrli:endDate>2025-01-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 3pt; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 3pt"></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 3pt">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES </b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549 </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>



<p style="font: 14pt Times New Roman, Times, Serif; margin: 3pt 0; text-align: center"><b>FORM <span id="xdx_902_edei--DocumentType_c20250106__20250106_z1IgM4A1MDeh"><ix:nonNumeric contextRef="AsOf2025-01-06" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span> </b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_90A_edei--DocumentPeriodEndDate_c20250106__20250106_zhs60LCegep3"><ix:nonNumeric contextRef="AsOf2025-01-06" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">January 6, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="font: 14pt Times New Roman, Times, Serif; margin: 6pt 0 0pt; text-align: center"><b><span id="xdx_907_edei--EntityRegistrantName_c20250106__20250106_ztuHzY1wOOsi"><ix:nonNumeric contextRef="AsOf2025-01-06" id="Fact000011" name="dei:EntityRegistrantName">INSEEGO CORP.</ix:nonNumeric></span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in
Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; text-align: center; width: 33%"><span style="font-size: 10pt"><b><span id="xdx_905_edei--EntityIncorporationStateCountryCode_c20250106__20250106_zIOWANnDWZo4"><ix:nonNumeric contextRef="AsOf2025-01-06" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_905_edei--EntityFileNumber_c20250106__20250106_zWrKHJaymina"><ix:nonNumeric contextRef="AsOf2025-01-06" id="Fact000013" name="dei:EntityFileNumber">001-38358</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 33%"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20250106__20250106_zJnA9nBY4zyg"><ix:nonNumeric contextRef="AsOf2025-01-06" id="Fact000014" name="dei:EntityTaxIdentificationNumber">81-3377646</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or
                                    other jurisdiction</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">of incorporation)</p></td>
    <td style="vertical-align: bottom"><b>&#160;</b></td>
    <td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Commission
File Number)</p></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(IRS Employer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification No.)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_900_edei--EntityAddressAddressLine1_c20250106__20250106_zpAQOOXiGfV4"><ix:nonNumeric contextRef="AsOf2025-01-06" id="Fact000015" name="dei:EntityAddressAddressLine1">9710 Scranton Road</ix:nonNumeric></span>, <span id="xdx_903_edei--EntityAddressAddressLine2_c20250106__20250106_zvFcmCmIi0db"><ix:nonNumeric contextRef="AsOf2025-01-06" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 200</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90C_edei--EntityAddressCityOrTown_c20250106__20250106_z1vWWgvpMJg5"><ix:nonNumeric contextRef="AsOf2025-01-06" id="Fact000017" name="dei:EntityAddressCityOrTown">San Diego</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressStateOrProvince_c20250106__20250106_zk05RX6KrhHc"><ix:nonNumeric contextRef="AsOf2025-01-06" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span> <span id="xdx_900_edei--EntityAddressPostalZipCode_c20250106__20250106_z0LwBmmmcffb"><ix:nonNumeric contextRef="AsOf2025-01-06" id="Fact000019" name="dei:EntityAddressPostalZipCode">92121</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices) (Zip
Code) <b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <b>(<span id="xdx_90B_edei--CityAreaCode_c20250106__20250106_zBr8bhZ5MUw1"><ix:nonNumeric contextRef="AsOf2025-01-06" id="Fact000020" name="dei:CityAreaCode">858</ix:nonNumeric></span>)</b><b> <span id="xdx_90F_edei--LocalPhoneNumber_c20250106__20250106_zBChVVZJghWi"><ix:nonNumeric contextRef="AsOf2025-01-06" id="Fact000021" name="dei:LocalPhoneNumber">812-3400</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Not Applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span id="xdx_901_edei--WrittenCommunications_c20250106__20250106_z78TpQtxcnE"><ix:nonNumeric contextRef="AsOf2025-01-06" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></td>
    <td style="width: 96%"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span id="xdx_90D_edei--SolicitingMaterial_c20250106__20250106_z0faX8tRA6F5"><ix:nonNumeric contextRef="AsOf2025-01-06" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></td>
    <td style="width: 96%"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span id="xdx_90E_edei--PreCommencementTenderOffer_c20250106__20250106_zeDymAogYOe2"><ix:nonNumeric contextRef="AsOf2025-01-06" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></td>
    <td style="width: 96%"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span id="xdx_90D_edei--PreCommencementIssuerTenderOffer_c20250106__20250106_zj7kdqHgvea4"><ix:nonNumeric contextRef="AsOf2025-01-06" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></td>
    <td style="width: 96%"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
  <tr style="vertical-align: middle">
    <td style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; width: 38%"><b>Title of each class</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; width: 24%"><b>Trading Symbol(s)</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; width: 38%"><b>Name of each exchange on which registered</b></td></tr>
  <tr style="vertical-align: middle">
    <td rowspan="4" style="text-align: center; font-size: 10pt"><p style="margin-top: 0; margin-bottom: 0"><span id="xdx_901_edei--Security12bTitle_c20250106__20250106_zLeTo7P0Wr8g"><ix:nonNumeric contextRef="AsOf2025-01-06" id="Fact000026" name="dei:Security12bTitle">Common
                                            Stock, par value $0.001 per share</ix:nonNumeric></span></p></td>
    <td rowspan="4" style="text-align: center; font-size: 10pt"><span id="xdx_908_edei--TradingSymbol_c20250106__20250106_zzvM9dgG5dB4"><ix:nonNumeric contextRef="AsOf2025-01-06" id="Fact000027" name="dei:TradingSymbol">INSG</ix:nonNumeric></span></td>
    <td rowspan="4" style="text-align: center; font-size: 10pt"><span id="xdx_902_edei--SecurityExchangeName_c20250106__20250106_zof12ZPLBDJ1"><ix:nonNumeric contextRef="AsOf2025-01-06" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span>
    Global Select Market</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company <span id="xdx_90E_edei--EntityEmergingGrowthCompany_c20250106__20250106_zMiABjCJKnTi"><ix:nonNumeric contextRef="AsOf2025-01-06" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. &#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 10%; font-size: 10pt"><span style="font-size: 10pt"><b>Item 5.02.</b></span></td>
    <td style="text-align: justify; width: 90%; font-size: 10pt"><span style="font-size: 10pt"><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officer.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Appointment of Chief Executive Officer</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The board of directors (the
&#8220;Board) of Inseego Corp. (&#8220;Inseego&#8221; or the &#8220;Company&#8221;) has appointed Juho Sarvikas as Chief Executive Officer
of the Company, effective January 6, 2025. As described below, Mr. Sarvikas was also appointed as a member of the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Sarvikas, 42, has worked
most recently as president of North America for Qualcomm Incorporated, a leading global provider of connected computing technologies,
since April 2021. Prior to Qualcomm, Mr. Sarvikas served as Chief Product Officer of HMD Global from 2016 to April 2021, and as President
North America from May 2020 to April 2021. Before joining HMD Global, he led Nokia&#8217;s feature phone business under Microsoft and
held various leadership roles at Nokia for eight years prior to Microsoft&#8217;s acquisition of its smartphone business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are no arrangements
or understandings between Mr. Sarvikas and any other persons pursuant to which he was selected as an officer of the Company. There are
also no family relationships between Mr. Sarvikas and any director or executive officer of the Company, and he has no direct or indirect
material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="text-decoration: underline">Offer Letter with Juho
Sarvikas</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company entered into an
offer letter with Mr. Sarvikas (the &#8220;Offer Letter&#8221;) setting forth the terms of his employment as the Company&#8217;s Chief
Executive Officer. The following description of the Offer Letter is qualified in its entirety by reference to the copy of the Offer Letter
which is included as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Salary and Bonus.</i> The
Offer Letter provides for an annual base salary of $500,000, subject to review and potential increase at least annually, in the discretion
of the compensation committee (the &#8220;Compensation Committee&#8221;) of the Board. Mr. Sarvikas will be eligible to participate in
the Company&#8217;s annual cash bonus program with an annual target bonus equal to 75% of his base salary, subject to the achievement
of criteria to be established by the Compensation Committee each year. Mr. Sarvikas will be eligible to participate in other benefit programs
that the Company establishes and makes available to its employees from time to time, to the same extent available to similarly situated
employees of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Term and Termination.</i>
The Offer Letter has no specific term and is subject to termination by either the Company or Mr. Sarvikas at any time with or without
cause.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Inducement Equity Awards.</i>
Pursuant to the Offer Letter, as an inducement to accepting the appointment as the Company&#8217;s new Chief Executive Officer, Mr. Sarvikas
received the following equity awards (the &#8220;Inducement Awards&#8221;): (i) options to purchase 855,000 shares of common stock, which
are subject to both stock price performance exercisability requirements and time vesting requirements; (ii) $1.8 million worth of restricted
stock units which are subject to both stock price performance vesting requirements and time vesting during the performance period; and
(iii) $1.33 million worth of restricted stock units which are subject time vesting over four years. The specific terms of the Inducement
Awards are set forth in the Offer Letter. The Inducement Awards were issued as an employment inducement award in accordance with NASDAQ
Listing Rule 5635(c)(4).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="text-decoration: underline">Change in Control Agreement</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will enter into
a Change in Control and Severance Agreement (the &#8220;Severance Agreement&#8221;) with Mr. Sarvikas. The following description of the
Severance Agreement is qualified in its entirety by reference to the form of Severance Agreement attached as an exhibit to the Offer Letter
which is included as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference. The Severance Agreement will
provide that if Mr. Sarvikas is terminated without &#8220;Cause&#8221; or resigns for &#8221;Good Reason&#8221;, as such terms are defined
in the Severance Agreement (a &#8220;Covered Termination&#8221;), during the period commencing 120 days prior to a &#8220;Change in Control&#8221;
and ending on the 24-month anniversary of such &#8220;Change in Control&#8221;, as such term is defined in the Severance Agreement (a
&#8220;Change in Control Period&#8221;), Mr. Sarvikas will, subject to certain conditions including the execution of a general release,
be entitled to receive severance in an amount equal to the sum of 18 months of his then-current annual base salary, plus an amount equal
to 12 months of his then-current annual target bonus opportunity. If the termination occurs prior to the payment of an annual cash bonus
award with respect to the prior completed fiscal year, Mr. Sarvikas will also receive an amount equal to 100% of his annual target cash
bonus opportunity for such prior completed fiscal year. In the event of a change in control, (i) all then-outstanding stock options granted
to Mr. Sarvikas shall immediately become fully vested and exercisable with respect to 100% of the shares subject to such options; (ii)
100% of all then-outstanding unvested time-based equity awards granted to Mr. Sarvikas shall immediately become fully vested; and (iii)
100% of all then-outstanding unvested performance-based equity awards granted to Mr. Sarvikas shall immediately become fully vested, subject
to achievement of the applicable performance thresholds based on the value received by the Company&#8217;s stockholders in connection
with the change in control. In addition, Mr. Sarvikas and his covered dependents will be entitled to certain healthcare benefits for a
period of up to 18 months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of a Covered
Termination other than during a Change in Control Period, Mr. Sarvikas will, subject to certain conditions including the execution of
a general release, be entitled to receive severance in an amount equal to the sum of 18 months of his then-current annual base salary,
plus a payment equal to the pro-rated portion of the target bonus in the year of termination. In addition, if the termination occurs prior
to the payment of an annual cash bonus award with respect to the prior completed fiscal year, Mr. Sarvikas will also receive an amount
equal to the bonus payment he would be entitled to for such prior completed fiscal year, based on actual achievement of corporate and
personal performance goals and criteria during such prior completed year. In addition, Mr. Sarvikas&#8217;s outstanding equity awards
will become vested and, if applicable, exercisable with respect to that number of shares of Company common stock that would have vested
had Mr. Sarvikas continued employment with the Company for six months following the date of termination (subject to certain additional
requirements in the case of awards with performance-based criteria), and Mr. Sarvikas and his covered dependents will be entitled to certain
healthcare benefits for a period of up to 9 months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><span style="text-decoration: underline">Indemnification Agreement</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and Mr. Sarvikas
will enter into the Company&#8217;s standard form of indemnification agreement that the Company has entered into with each of its executive
officers and directors, which was filed as Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on August
21, 2017, and is incorporated herein by reference. The agreement requires the Company, among other things, to indemnify Mr. Sarvikas against
liabilities that may arise by reason of his service to the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Appointment of Directors</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board approved an increase
in the size of the Board from four to six members and appointed Mr. Sarvikas and Brian Miller to fill the vacancies created by the increase
in the size of the Board, with such appointments effective as of January 6, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Sarvikas became a member
of the class of directors with terms expiring at the 2027 Annual Meeting of the Stockholders of the Company. Mr. Sarvikas has not been
appointed to any Board committees at this time. Except for the Offer Letter described above, there is no arrangement or understanding
pursuant to which Mr. Sarvikas was appointed as a director, and there are no related party transactions between the Company and Mr. Sarvikas
that would require disclosure under Item 404(a) of Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon his appointment to the
Board, Mr. Miller became a member of the class of directors with terms expiring at the 2025 Annual Meeting of the Stockholders of the
Company. The Board has determined that Mr. Miller qualifies as &#8220;independent&#8221; in accordance with the published listing requirements
of the Nasdaq Stock Market. Mr. Miller has not been appointed to any Board committees at this time. There is no arrangement or understanding
pursuant to which Mr. Miller was appointed as a director.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Miller is Chief Investment
Officer of North Sound Partners. All transactions between the Company, affiliates of North Sound Partners, and Mr. Miller that would require
disclosure under Item 404(a) of Regulation S-K have been previously disclosed by the Company in its Definitive Proxy Statement on Schedule
14A filed by the Company with the Securities and Exchange Commission (the &#8220;Commission&#8221;) on August 22, 2024, and in its Current
Reports on Form 8-K filed by the Company with the Commission on September 11, 2024 and November 12, 2024, which disclosures are incorporated
by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For his services on the Board,
Mr. Miller will receive the same compensation as other non-management directors, as described in the Company&#8217;s Definitive Proxy
Statement on Schedule 14A filed with the SEC on August 22, 2024. Accordingly, Mr. Miller will receive an initial equity award upon joining
the Board in the form of restricted stock units (&#8220;RSUs&#8221;) with an economic value of $145,000. The RSUs vest in three equal
annual installments beginning with the first anniversary of the grant date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with Mr. Miller&#8217;s
appointment as a director of the Company, the Company and Mr. Miller will enter into an indemnification agreement, the terms of which
are identical in all material respects to the form of indemnification agreement that the Company has previously entered into with each
of its directors, which was filed as Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on August 21, 2017
and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 10%; font-size: 10pt"><span style="font-size: 10pt"><b>Item 7.01.</b></span></td>
    <td style="width: 90%; font-size: 10pt"><span style="font-size: 10pt"><b>Regulation FD&#8239; Disclosure.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company issued a press
release on January 6, 2025, announcing the appointment of Mr. Sarvikas as Chief Executive Officer and the appointments of Messrs. Sarvikas
and Miller to the Board. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information in this Item
7.01, including Exhibit 99.1, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended (the "Exchange Act"), or otherwise subject to liabilities under that section, and shall not be deemed
to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless
of any general incorporation language in such filings. This Current Report on Form 8-K will not be deemed an admission as to the materiality
of any information of the information in this Item 7.01.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white"><tr style="vertical-align: top">
<td style="width: 10%"><b>Item 9.01.</b></td><td style="width: 90%"><b>Financial Statements and Exhibits.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2" style="padding-left: 6pt"><span style="font-size: 10pt"><i>(d) Exhibits.</i></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 6%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 93%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="inseego_ex1001.htm">Offer Letter dated December 6, 2024, between Inseego Corp. and Juho Sarvikas.</a></span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">99.1</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="inseego_ex9901.htm">Press Release dated January 6, 2025.</a></span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-transform: uppercase"><b></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">SIGNATURE</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the
undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt"><b>INSEEGO CORP.</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 51%">&#160;</td>
    <td style="width: 4%">&#160;</td>
    <td style="width: 42%">&#160;</td>
    <td style="width: 3%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">Date:&#160;&#160; January 6, 2025</span></td>
    <td><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-size: 10pt">/s/ Steven Gatoff</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Name: Steven Gatoff</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Title: Chief Financial Officer</span></td>
    <td>&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2OUqXhPKtpCKyCInodckplnRHZjfTT+ov25RoGBiGe8+9QozEhta6RIbLMs/ghFVdKoeQ4w0ZzRW9I93uEvA3x7u2jpVx/fsDU/IMeiYeS6m80FsbbbFIIJxOotlETiGcJ/EMFnsRfPWUzE0XaJxWJShTwJGpZo1OcTcknFRLhqqurzojW00mgWgcDvIbZBhJOFCjXsQPC1mWimDUTyA2TM/au1atQ/MlYVVi5evsQP83+AAGgkqM -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>inseego_ex1001.htm
<DESCRIPTION>OFFER LETTER DATED DECEMBER 6, 2024, BETWEEN INSEEGO CORP. AND JUHO SARVIKAS.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B><IMG SRC="image_001.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">December 6, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 403.25pt; margin-bottom: 0pt">Juho Sarvikas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">RE: Offer of Employment at Inseego Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Dear Juho:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">It is my pleasure to make you the following offer of employment
with Inseego Corp., (&ldquo;Company&rdquo;), as Chief Executive Officer. This offer of employment is conditioned on your satisfactory
completion of certain requirements, as more fully explained in this letter. Your employment is subject to the terms and conditions set
forth in this letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><U>Duties</U>: In your capacity as Chief Executive
Officer, you will perform duties and responsibilities that are commensurate with your position and such other duties as may be assigned
to you from time to time. You will report to the Board of Directors of the Company (the &ldquo;Board&rdquo;). This is an exempt, full-time
position located in San Diego. You agree to devote your full business time, attention, and best efforts to the performance of your duties
and to the furtherance of the Company's interests. Notwithstanding the foregoing, nothing in this letter shall preclude you from devoting
reasonable periods of time to charitable and community activities, managing personal investment assets and, subject to Board approval
which will not be unreasonably withheld, serving on boards of other companies (public or private) not in competition with the Company,
provided that none of these activities interferes with the performance of your duties hereunder or creates a conflict of interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><U>Start Date</U>: Subject to satisfaction of all the
conditions described in this letter, your anticipated start date is January 6, 2025 (&quot;Start Date&quot;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><U>Board
Seat</U>: Effective as of the Start Date, you will be appointed as a non-independent director serving on the Board in your role of
Chief Executive Officer. We will cause your nomination for election to the Board in future years while
you serve as our Chief Executive Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 403.25pt; margin-bottom: 0pt">Mr. Juho Sarvikas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 403.25pt; margin-bottom: 0pt">Page 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 403.25pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 403.25pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><U>Base Salary</U>: You will receive an initial bi-weekly
salary in the amount of USD $ 19,230.76 paid in accordance with our normal payroll procedures. This is equivalent to $500,000 on an annualized
basis. At least annually, the Compensation Committee of the Board will consider whether, in its discretion, to increase, but not decrease,
your rate of base salary, based on market trends, internal considerations, performance or such other factors as the Compensation Committee
may determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><U>Annual
Bonus</U>: Beginning with 2025, you will be eligible to participate in the Company's annual bonus plan on the same terms and
conditions as other similarly situated executives. Each year your target bonus opportunity will be not less than 75% of your base
salary. Actual payments will be determined based on criteria established by the Compensation Committee of the Board. Bonus payments
will be subject to the terms and conditions of the bonus plan and the Severance Agreement (as that is defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><U>Benefits</U>: You will be eligible to participate
in the employee benefit plans and programs generally available to the Company's employee, including group medical, dental, vision and
life insurance, disability benefits, 401(k) plan, and employee stock purchase plan, subject to the terms and conditions of such plans
and programs. You will be entitled to paid time off in accordance with the Company's policies in effect from time to time. The Company
reserves the right to amend, modify or terminate any of its benefit plans or programs at any time and for any reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><U>Change in Control; Severance</U>: You will be eligible
to receive those severance and other benefits set forth in your Change in Control and Severance Agreement (the &ldquo;Severance Agreement&rdquo;),
which is attached to this offer letter as <U>Exhibit A</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><U>Indemnification</U>: You will also be authorized
to enter into the Company&rsquo;s standard form of Indemnification Agreement for directors and executive officers. The Company will cover
you under the Company&rsquo;s directors&rsquo; and officers&rsquo; liability insurance both during, and while potential liability exists,
after employment in the same amount and to the same extent as the Company covers its other officers and directors.
These obligations will survive the termination of your employment with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 30.05pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 30.05pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 30.05pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 30.05pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 30.05pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 30.05pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 30.05pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 30.05pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 30.05pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;<IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 403.25pt; margin-bottom: 0pt">Mr. Juho Sarvikas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 403.25pt; margin-bottom: 0pt">Page 3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><U>Equity Awards</U>: As a material inducement for
you to join the Company, you will be granted an initial award of stock options and restricted stock units on your Start Date, as follows
(all as more particularly described on <U>Schedule A</U> hereto):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 44.9pt"></TD><TD STYLE="width: 22.6pt">(a)</TD><TD STYLE="padding-right: 59.2pt">$1.80 million of restricted stock units will be subject to performance vesting requirements and continued
service during the performance period generally applicable to such awards;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 44.9pt"></TD><TD STYLE="width: 22.6pt">(b)</TD><TD STYLE="padding-right: 37.65pt">$1.33 million of restricted stock units will be subject to time vesting requirements only; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 44.9pt"></TD><TD STYLE="width: 22.6pt">(c)</TD><TD STYLE="padding-right: 53.7pt">850,000 stock options shall be subject to both stock price performance vesting requirements and time
vesting during the performance period.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">The inducement awards will be granted outside of
the Company&rsquo;s stockholder-approved equity incentive plan as stand-alone inducement awards as permitted by Nasdaq Listing Rule 5635(c)(4)
(and in compliance with those listing rules). Each award will be documented by an award agreement substantially in the forms attached
to this letter as <U>Exhibits B</U>, <U>C</U> and <U>D</U>, which in all cases will control except to the extent any provision of the
Severance Agreement related to equity vesting are more favorable to you. In addition, disposing of the underlying shares issuable upon
exercise of stock options shall be subject to the Company&rsquo;s Insider Trading Policy. All such equity awards have been approved by
the Board on or prior to the date of this offer letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">In the future, you will be eligible
to receive additional equity incentive awards from time- to-time in such value as determined by the Compensation Committee and in such
mix and on such terms as the Compensation Committee may determine, consistent with the design for the Company&rsquo;s other executive
officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><U>Clawback</U>: Any amounts payable hereunder are subject
to any policy (whether currently in existence or later adopted) established by the Company providing for clawback or recoveryof amounts that were paid to you. The Company will make
any determination for clawback or recovery in its sole discretion and in accordance with any applicable law or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><U>Governing Law</U>: This offer letter shall be governed
by the laws of California, without regard to conflict of law principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><U>Contingent Offer</U>: This offer is contingent
upon (a) verification of your right to work in the United States, as demonstrated by your completion of an I-9 form upon hire and your
submission of acceptable documentation (as noted on the I-9 form) verifying your identity and work authorization within three days of
your Start Date; and (b) satisfactory completion of a background investigation. This offer may be withdrawn if any of the above conditions
are not reasonably satisfied.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 403.25pt; margin-bottom: 0pt">Mr. Juho Sarvikas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 403.25pt; margin-bottom: 0pt">Page 4</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><U>Governing Law</U>: This offer letter shall be governed
by the laws of California, without regard to conflict of law principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><U>Contingent Offer</U>: This offer is contingent
upon (a) verification of your right to work in the United States, as demonstrated by your completion of an I-9 form upon hire and your
submission of acceptable documentation (as noted on the I-9 form) verifying your identity and work authorization within three days of
your Start Date; and (b) satisfactory completion of a background investigation. This offer may be withdrawn if any of the above conditions
are not reasonably satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><U>General Requirements</U>: You will be required to
sign an Inventions, Disclosure, Confidentiality &amp; Proprietary Rights Agreement with the Company on the commencement date of your employment.
In addition, you will be required during your employment to abide by the Company&rsquo;s Code of Business Conduct and Ethics and customary
employment policies and procedures that apply to all Company employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><U>At-Will Employment</U>: Please note your employment
at the Company is employment at will, which means that either you or the Company can terminate your employment at any time with or without
cause or advance notice, subject to the provisions of the Severance Agreement. By signing below, you agree that no other promises or material
terms of employment have been offered to you other than as set forth herein and that this offer letter may be modified or supplemented
only in writing, manually signed by both you and either the Chief Administrative Officer or the Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><U>Representations</U>: By accepting this offer, you
represent that you are able to accept this job and carry out the work that it would involve without breaching any legal restrictions on
your activities, such as non-competition, non-solicitation or other work-related restrictions imposed by a current or former employer.
You also represent that you will inform the Company about any such restrictions and provide the Company with as much information about
them as possible, including any agreements between you and your current or former employer describing such restrictions on your activities.
You further confirm that you will not remove or take any documents or proprietary data
or materials of any kind, electronic or otherwise, with you from your current or former employer to the Company without written authorization
from your current or former employer, nor will you use or disclose any such confidential information during the course and scope of your
employment with the Company. If you have any questions about the ownership of particular documents or other information, you should discuss
such questions with your former employer before removing or copying the documents or information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><IMG SRC="image_002.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 403.25pt; margin-bottom: 0pt">Mr. Juho Sarvikas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 403.25pt; margin-bottom: 0pt">Page 5</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">We are excited at the prospect of you joining our team.
If you have any questions about the above details, please feel free to contact Kurt Scheuerman, our Chief Administration Officer &amp;
General Counsel, at (858) 812-8098. If you wish to accept this position, please sign below and return this letter to Mr. Scheuerman as
soon as possible. This offer is open for you to accept until December 8, 2024, at which time it will be deemed to be withdrawn.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">I look forward to working with you as a member of
the Inseego team.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 105.15pt 0pt 26.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 105.15pt; margin-bottom: 0pt">/s/ Philip Brace</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 390.3pt 0pt 26.95pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 390.3pt 0pt 26.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 390.3pt; margin-bottom: 0pt">Philip Brace</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 390.3pt; margin-bottom: 0pt">Executive Chairman</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><U>Acceptance of Offer</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">I have read and understand, and I accept all the terms
of the offer of employment as set forth in the foregoing letter. I have not relied on any agreements or representations, express or implied,
that are not set forth expressly in the foregoing letter, and this letter supersedes all prior and contemporaneous understandings, agreements,
representations and warranties, both written and oral, with respect to the subject matter of this letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">JUHO SARVIKAS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 279.85pt; margin-bottom: 0pt">Signed: /s/ Juho Sarvikas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 279.85pt; margin-bottom: 0pt">Date: December 7, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 279.85pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 279.85pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 279.85pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 279.85pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 279.85pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 279.85pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 279.85pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 279.85pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 279.85pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 279.85pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 279.85pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 279.85pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 279.85pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 279.85pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 279.85pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 279.85pt 0pt 27pt"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 279.85pt 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><IMG SRC="image_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.15pt; text-align: center">SCHEDULE A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 18.7pt 0pt 17.75pt; text-align: center"><B>INDUCEMENT EQUITY AWARD PROPOSAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B><U>Stock Options</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border: black 1pt solid; padding-left: 5.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares</FONT></TD>
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">850,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="5" STYLE="width: 26%; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 5.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise Price</FONT></TD>
    <TD STYLE="width: 29%; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-left: 0.35pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Shares</U></FONT></TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-left: 0.3pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Exercise Price</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.35pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">200,000</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.3pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Grant date FMV*</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.35pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">210,000</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.3pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Grant date FMV* +$5</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.35pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">215,000</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.3pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Grant date FMV* + $10</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.35pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">225,000</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.3pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Grant date FMV* +$15</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 5.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Time Vesting</FONT></TD>
    <TD COLSPAN="2" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 33.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4 Year vesting - 25% first year, 1/48<SUP>th</SUP> per month thereafter</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 5.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Performance Vesting</FONT></TD>
    <TD COLSPAN="2" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt">To become exercisable, in addition to time-based vesting,
    the closing trading price of INSG must have exceeded the exercise price for 20</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt">days within a 30-trading day period prior to the date of
    exercise.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.35pt">* Grant date FMV shall be determined based the weighted-average
    closing price of Inseego&rsquo;s</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.95pt">common stock for the period of December 9, 2024 through
    January 3, 2025.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><B><U>Performance RSUs</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.35pt">Grant date FMV* of</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.35pt">Shares</P></TD>
    <TD COLSPAN="6" STYLE="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.55pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$1,800,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 5.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Time Vesting</FONT></TD>
    <TD COLSPAN="6" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.55pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3-year cliff vesting</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 5.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Performance Vesting</FONT></TD>
    <TD COLSPAN="6" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 5.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Percentage of shares vesting will be based on INSG performance relative to the total shareholder return of Russell Microcap Index (&ldquo;rTSR&rdquo;) over the vesting period. The baseline share price for purposes of the rTSR calculation will be determined based the weighted-average closing price of Inseego&rsquo;s common stock for the period of December 9, 2024 through January 3, 2025.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="width: 26%; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 5.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payout Matrix</FONT></TD>
    <TD STYLE="width: 29%; padding-left: 0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif">rTSR percentile</FONT></TD>
    <TD STYLE="width: 45%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&lt;40%</FONT></TD>
    <TD STYLE="width: 0; padding-left: 1.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">40%</FONT></TD>
    <TD STYLE="width: 9%; padding-left: 0.95pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">50%</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">60%</FONT></TD>
    <TD STYLE="width: 12%; border-right: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">80%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; padding-left: 0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payout</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding-left: 1.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">30%</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding-left: 0.95pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">40%</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">100%</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">200%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="7" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.35pt">* Grant date FMV shall be determined based the weighted-average
    closing price of Inseego&rsquo;s</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.95pt">common stock for the period of December 9, 2024 through
    January 3, 2025.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><B><U>Time-Based RSUs</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 26%; border: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.35pt">Grant date FMV* of</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.35pt">Shares</P></TD>
    <TD STYLE="width: 74%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$1,333,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 5.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Time Vesting</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">4-year vesting &ndash; 25% on first anniversary; 1/48<SUP>th</SUP> per month thereafter</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 5.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Performance Vesting</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">N/A</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.35pt">* Grant date FMV shall be determined based the weighted-average
    closing price of Inseego&rsquo;s</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.95pt">common stock for the period of December 9, 2024 through
    January 3, 2025.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center"><U>EXHIBIT A</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 18.7pt 0pt 17.75pt; text-align: center"><B><U>CHANGE IN CONTROL AND SEVERANCE
AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 18.7pt 0pt 17.75pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 33.55pt 0pt 26.95pt; text-align: justify; text-indent: 0.25in">This Change
in Control and Severance Agreement (the &ldquo;<U>Agreement</U>&rdquo;) is made and entered into by and between Juho Sarvikas (<B><I>&ldquo;Executive&rdquo;</I></B>)
and Inseego Corp., a Delaware corporation (the <B><I>&ldquo;Company&rdquo;</I></B>), this [<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT>]
day of January, 2025 (the <B><I>&ldquo;Effective Date&rdquo;</I></B>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 33.55pt 0pt 26.95pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.25in"><B>WHEREAS, </B>the Board of
Directors of the Company (the <B><I>&ldquo;Board&rdquo;</I></B>) recognizes the importance of Executive&rsquo;s role at the Company and
that the possibility of an acquisition of the Company or an involuntary termination can be a distraction to Executive and can cause Executive
to consider alternative employment opportunities. The Board has determined that it is in the best interests of the Company and its stockholders
to assure that the Company will have the continued dedication and objectivity of Executive, notwithstanding the possibility, threat or
occurrence of such an event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.85pt 0pt 26.95pt; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.25in"><B>WHEREAS, </B>the Board believes
that it is in the best interests of the Company and its stockholders to provide Executive with an incentive to continue Executive&rsquo;s
employment and to motivate Executive to maximize the value of the Company upon a Change in Control (as defined below) for the benefit
of its stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.45in 0pt 27pt; text-indent: 17.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.25in"><B>WHEREAS,</B> the Board believes
that it is imperative to provide Executive with severance benefits upon certain terminations of Executive&rsquo;s service to the Company
that enhance Executive&rsquo;s financial security and provide incentive and encouragement to Executive to remain with the Company notwithstanding
the possibility of such an event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.25in"><B>WHEREAS,</B> unless otherwise
defined herein, capitalized terms used in this Agreement are defined in Section 9 below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.25in"><B>NOW, THEREFORE, </B>in consideration
of the foregoing, and for other good and valuable consideration, including the agreements set forth below, the receipt and sufficiency
of which are hereby acknowledged, the parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt; text-indent: 17.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 17.95pt">1.</TD><TD><U>Term of Agreement.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: 17.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">This Agreement shall become effective
as of the Effective Date and terminate upon the date that all obligations of the parties hereto with respect to this Agreement have been
satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: 17.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: 17.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: 17.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: 17.95pt"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: 17.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 17.95pt">2.</TD><TD><U>At-Will Employment.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">The Company and Executive acknowledge
that Executive&rsquo;s employment shall be &ldquo;at-will,&rdquo; as defined under applicable law. If Executive&rsquo;s employment terminates
for any reason, Executive shall not be entitled to any payments, benefits, damages, awards or compensation other than as provided by this
Agreement, the Indemnification Agreement between the Company and Executive entered into on or about the date hereof (the <B><I>&ldquo;Indemnification
Agreement&rdquo;</I></B>), the Company&rsquo;s bylaws (as may be amended from time to time), the Company&rsquo;s Amended and Restated
Certificate of Incorporation (as may be amended from time to time), and/or any other agreement evidencing the grant to Executive of equity
compensation that is concurrently or hereafter entered into by the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 17.95pt">3.</TD><TD><U>Covered Termination Other Than During a Change in Control Period.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">If Executive experiences a Covered
Termination other than during a Change in Control Period, and if Executive delivers to the Company a general release of all claims against
the Company and its affiliates, in the form provided by the Company which shall be substantially in the form attached as <U>Exhibit A</U>
(which form may be modified by the Company to comply with the facts and applicable law) (a <B><I>&ldquo;Release of Claims&rdquo;</I></B>)
that becomes effective within 55 days following the Covered Termination and irrevocable within 62 days following the Covered Termination
(the <B><I>&ldquo;Release Requirements&rdquo;</I></B>), then in addition to any accrued but unpaid salary, accrued but unused vacation,
incurred but unreimbursed business expenses payable in accordance with applicable law, or vested benefits (other than severance) under
any Company benefit plan as of the date of the Covered Termination (the <B><I>&ldquo;Accrued Amounts&rdquo;</I></B>) the Company shall
provide Executive with the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U>Severance</U>.
Executive shall be entitled to receive an amount equal to eighteen (18) months of his or her base salary, payable in cash in the
form of salary continuation, commencing on the first normally-scheduled Company payroll date that is at least 75 days following the
Termination Date (with any such amounts that normally would have been payable during the period between the Termination Date and
such first payment being included in such first payment), less authorized deductions and applicable withholding taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 33.1pt 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Equity Awards</U>. In the event of a Covered Termination, (i) all stock options and restricted stock unit awards that vest solely
based upon Executive&rsquo;s continued employment shall immediately become vested with respect to that number of units or shares of the
Company&rsquo;s common stock, as applicable, that would have vested had Executive continued employment with the Company for six months
following the Termination Date; (ii) all stock options that vest based upon both Executive&rsquo;s continued employment and the achievement
of performance criteria shall immediately become vested with respect to that number of shares of the Company&rsquo;s common stock that
would have vested had (A) Executive continued employment with the Company for six months following the Termination Date to the extent
that the relevant performance-based conditions to exercisability have been satisfied as of the Termination Date; and (iii) all performance
restricted stock units that vest based upon both Executive&rsquo;s continued employment and the achievement of performance criteria shall
immediately become fully vested with respect to that number of performance restricted stock units that would have vested if the Termination
Date was treated as the &ldquo;Measurement Date&rdquo; (as that term is used in the applicable Performance Stock Unit Agreement). All
such equity awards or the proceeds therefrom shall be held by the Company until such time as the Executive has timely satisfied the Release
Requirements. Executive may exercise the vested portion of any such stock option at any time until the earlier of (A) the date twelve
(12) months following the Termination Date or (B) the expiration date of such stock option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.45pt 0pt 26.95pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.45pt 0pt 26.95pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.45pt 0pt 26.95pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.45pt 0pt 26.95pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U>Continued
Healthcare</U>. If Executive elects to receive continued healthcare coverage pursuant to the provisions of the Consolidated Omnibus
Budget Reconciliation Act of 1985, as amended (<B><I>&ldquo;COBRA&rdquo;</I></B>), the Company shall directly pay the premium for
Executive and Executive&rsquo;s covered dependents, if any, through the earliest of (i) the nine (9) month anniversary of the
Termination Date, (ii) the date Executive and Executive&rsquo;s covered dependents, if any, become eligible for healthcare coverage
under another employer of Executive&rsquo;s plan(s) and (iii) the date that Executive and/or Executive&rsquo;s covered dependents,
if any, become no longer eligible for COBRA. Any such payment or reimbursement shall be subject to any required withholding taxes.
After the Company ceases to pay premiums pursuant to the preceding sentence, Executive may, if eligible, elect to continue
healthcare coverage at Executive&rsquo;s expense in accordance the provisions of COBRA. The Company shall have no obligation to make
any payment under this subsection (c) if it reasonably determines that doing so would cause adverse consequences under Section
105(h) of the Internal Revenue Code or the Patient Protection and Affordable Care Act or other similar law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.85pt 0pt 27pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Pro Rata Cash Bonus</U>. If the Covered Termination occurs prior to the payment of an annual cash bonus award with respect to
the prior completed year, Executive shall receive such unpaid award to the extent Executive would have received such award should he have
been employed on the date such awards are paid to other employees, but not later than March 15 of the year of the Covered Termination.
Such award shall be based on actual achievement of corporate and personal performance goals and criteria during such prior completed year
as reasonably determined by the Board (without the application of any negative discretion). In addition, Executive shall receive a pro
rata amount of Executive&rsquo;s target cash bonus award for the fiscal year of termination based on the number of days in the fiscal
year during which Executive was employed as compared to 365, which shall be paid to Executive at the time such bonuses normally are paid,
but not later than the March 15 of the calendar year following the Covered Termination. Any such pro rata bonus shall be paid in a single
cash lump sum, less authorized deductions and applicable withholding taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.35pt 0pt 26.95pt; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 17.95pt">4.</TD><TD><U>Covered Termination During a Change in Control Period.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: 17.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">If Executive experiences a Covered
Termination during a Change in Control Period, and if Executive satisfies the Release Requirements, then in addition to any Accrued Amounts,
but in lieu of any amounts the Executive otherwise could have received under Section 3 of this Agreement, the Company shall provide Executive
with the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: 17.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U>Severance</U>.
Executive shall be entitled to receive an amount equal to the sum of (i) eighteen (18) months of Executive&rsquo;s base salary, plus
(ii) if the termination occurs prior to the payment of an annual cash bonus award with respect to the prior completed fiscal year,
an amount equal to 100% of Executive&rsquo;s annual target cash bonus opportunity for such prior completed fiscal year, plus (iii)
an amount equal to 100% of the Executive&rsquo;s annual target cash bonus opportunity for the fiscal year of such termination, in
each case, at the rate in effect immediately prior to the Termination Date. The base salary component shall be payable in cash in
the form of salary continuation, commencing on the first normally-scheduled Company payroll date that is at least 75 days following
the Termination Date (with any such amounts that normally would have been payable during the period between the Termination Date and
such first payment being included in such first payment), less authorized deductions and applicable withholding taxes. The target
annual bonus component shall be payable in cash in a lump sum within 10 days of the date the Executive timely satisfied the Release
Requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.65pt 0pt 26.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Continued Healthcare</U>. If Executive elects to receive continued healthcare coverage pursuant to the provisions of COBRA,
the Company shall directly pay the premium for Executive and Executive&rsquo;s covered dependents, if any, through the earliest of (i)
the eighteen (18) month anniversary of the Termination Date, (ii) the date Executive and Executive&rsquo;s covered dependents, if any,
become eligible for healthcare coverage under another employer of Executive&rsquo;s plan(s) and (iii) the date that Executive and/or Executive&rsquo;s
covered dependents, if any, become no longer eligible for COBRA. Any such payment or reimbursement shall be subject to any required withholding
taxes. After the Company ceases to pay premiums pursuant to the preceding sentence, Executive may, if eligible, elect to continue healthcare
coverage at Executive&rsquo;s expense in accordance the provisions of COBRA. The Company shall have no obligation to make any payment
under this subsection (c) if it reasonably determines that doing so would cause adverse consequences under Section 105(h) of the Internal
Revenue Code or the Patient Protection and Affordable Care Act or other similar law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.9pt 0pt 27pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.9pt 0pt 27pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.9pt 0pt 27pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.9pt 0pt 27pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.9pt 0pt 27pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination Within 120 Days Before a Change in Control</U>. In the event Executive is terminated prior to the closing of a Change
in Control, but during the Change in Control Period, then Executive initially shall receive the amounts under Section 3 hereof, and (i)
Executive shall receive the target annual bonus amount described in Section 4(a), less any amount paid under Section 3(d), within 10 days
of the Change in Control, (ii) Section 5 shall apply to all equity incentive awards held by Executive immediately prior to the Termination
Date as if Executive had been employed by the Company and held all such equity incentive awards on the date of the Change in Control,
and (iii) the reference to &ldquo;nine (9) months&rdquo; in Section 3(c) shall be extended to eighteen months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.7pt 0pt 26.95pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>In Contemplation</U>. In the event Executive is terminated in Contemplation of a Change in Control, Executive initially shall
receive the amounts under Section 3 hereof, provided that, if the Change of Control actually occurs within 12 months following such termination,
that Change in Control satisfies the requirements of Treasury Regulation 1.409A-3(i)(5), and the Executive timely satisfied the Release
Requirements, then (i) the Executive shall receive the target annual bonus amount described in Section 4(a), less any amount paid under
Section 3(d), within 10 days of the Change in Control, (ii) Section 5 shall apply to all equity incentive awards held by Executive immediately
prior to the Termination Date as if Executive had been employed by the Company and held all such equity incentive awards on the date of
the Change in Control, and (iii) the reference to &ldquo;nine (9) months&rdquo; in Section 3(c) shall be extended to eighteen (18) months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 17.95pt">5.</TD><TD><U>Acceleration of Equity Incentive Awards.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.75pt 0pt 26.95pt; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">In the event of a Change in
Control, notwithstanding any provision of the applicable equity award agreement or this Agreement to the contrary, (i) all then-outstanding
stock options granted to Executive shall immediately become fully vested and exercisable with respect to one hundred percent (100%) of
the shares subject to such options; (ii) one hundred percent (100%) of all then-outstanding unvested time-based equity awards granted
to Executive shall immediately become fully vested; and (iii) one hundred percent (100%) of all then-outstanding unvested performance-based
equity awards granted to Executive shall immediately become fully vested, subject to achievement of the applicable performance thresholds
based on the value received by the Company&rsquo;s stockholders in connection with the Change in Control. To the extent practicable, such
acceleration of vesting and exercisability shall occur in a manner and at a time which allows Executive the ability to participate in
the Change in Control with respect to the shares of common stock received. In all other respects Executive&rsquo;s equity awards shall
continue to be bound by and subject to the terms of their respective agreements and equity plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.75pt 0pt 26.95pt; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 44.95pt"></TD><TD STYLE="width: 18pt">6.</TD><TD><U>Other Terminations.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: 17.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">If Executive&rsquo;s service with
the Company is terminated by the Company or by Executive for any or no reason other than a Covered Termination, then Executive shall only
be entitled to Accrued Amounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: 17.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 17.95pt">7.</TD><TD><U>Deemed Resignation.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt; text-indent: 17.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">Upon termination of Executive&rsquo;s
employment for any reason, Executive shall be deemed to have resigned from all offices and directorships, if any, then held with the Company
or any of its affiliates, and, at the Company&rsquo;s request, Executive shall execute such documents as are necessary or desirable to
effectuate such resignations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt; text-indent: 17.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt; text-indent: 17.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt; text-indent: 17.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt; text-indent: 17.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt; text-indent: 17.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt; text-indent: 17.95pt"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt; text-indent: 17.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 17.95pt">8.</TD><TD><U>Limitation on Payments.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.85pt 0pt 26.95pt; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">Notwithstanding anything in
this Agreement to the contrary, if any payment or distribution Executive would receive pursuant to this Agreement or otherwise (<B><I>&ldquo;Payment&rdquo;</I></B>)
would (a) constitute a &ldquo;parachute payment&rdquo; within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended
(the <B><I>&ldquo;Code&rdquo;</I></B>), and (b) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code
(the <B><I>&ldquo;Excise Tax&rdquo;</I></B>), then such Payment shall be reduced (but not below zero) if and to the extent that such reduction
would result in Executive retaining a larger amount, on an after-tax basis (taking into account the applicable federal, state and local
income and payroll taxes and the Excise Tax), than if Executive received all of the Payment. The Company shall reduce or eliminate the
Payment by first reducing or eliminating the portion of the Payment which is not payable in cash and then by reducing or eliminating cash
payments, in each case in reverse order beginning with payments or benefits which are to be paid the farthest in time from the determination.
The accounting firm engaged by the Company for general audit purposes as of the day prior to the effective date of the Change in Control
or, in the event such accounting firm is precluded from performing calculations hereunder or is serving as accountant or auditor for the
individual, entity or group effecting the Change in Control, such other accounting firm of national reputation as may be determined by
the Company, and reasonably acceptable to Executive, shall perform the foregoing calculations. The Company shall bear all expenses with
respect to the determinations by such accounting firm required to be made hereunder. The accounting firm shall provide its calculations
to the Company and Executive within fifteen (15) calendar days after the date on which Executive&rsquo;s right to a Payment is triggered
(if requested at that time by the Company or Executive) or such other time as requested by the Company or Executive. Any good-faith determinations
of the accounting firm made hereunder shall be final, binding and conclusive upon the Company and Executive. If the Accounting Firm determines
that no Excise Tax is payable by Executive, it shall furnish Executive with a written opinion that failure to report the Excise Tax on
Executive&rsquo;s applicable federal income tax return would not result in the imposition of a negligence or similar penalty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.85pt 0pt 26.95pt; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 17.95pt">9.</TD><TD><U>Definition of Terms.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">The following terms referred to in this Agreement shall have
the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp; </FONT><B><I>&ldquo;Cause&rdquo; </I></B>means
(i) any willful act of material misconduct or material dishonesty by Executive in the performance of his or her duties which is or
could reasonably be expected to be materially injurious to the business or reputation of the Company; (ii) any willful failure or
refusal by Executive to attempt in good faith to perform his or her duties to the Company or to follow the lawful and reasonable
instructions of the Board (except as a result of physical or mental incapacity or illness) which is not promptly cured after written
notice; (iii) Executive&rsquo;s commission of any fraud or embezzlement against the Company (whether or not a misdemeanor); (iv) any
material breach of any material obligation under any written agreement with the Company, which breach has not been cured by
Executive (if curable) within thirty (30) days after written notice thereof to Executive by the Company; (v) Executive&rsquo;s being
convicted of (or pleading guilty or nolo contendere to) any felony or misdemeanor involving theft, embezzlement, dishonesty or moral
turpitude; and/or (vi) Executive&rsquo;s failure to materially comply with the material policies of the Company in effect from time
to time relating to conflicts of interest, ethics, codes of conduct, insider trading, or discrimination and harassment, or other
breach of Executive&rsquo;s fiduciary duties to the Company, which failure or breach is or could reasonably be expected to be
materially injurious to the business or reputation of the Company. For purposes of this provision, no act or failure to act on the
part of the Executive shall be considered &ldquo;willful&rdquo; unless it is done, or omitted to be done, by the Executive in bad
faith or without reasonable belief that the Executive&rsquo;s action or omission was in the best interests of the Company. Any act,
or failure to act, based upon authority given pursuant to a resolution duly adopted by the Board or upon the advice of counsel for
the Company shall be conclusively presumed to be done, or omitted to be done, by the Executive in good faith and in the best
interests of the Company. Termination of the Executive&rsquo;s employment shall not be deemed to be for Cause unless and until the
Company delivers to the Executive a copy of a resolution duly adopted by the affirmative vote of not less than a majority of the
Board (after reasonable written notice is provided to the Executive and the Executive is given an opportunity, together with
counsel, to be heard before the Board), finding that the Executive has engaged in the conduct described in any of (i)-(vi)
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.45in 0pt 26.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.45in 0pt 26.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.45in 0pt 26.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.45in 0pt 26.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.45in 0pt 26.95pt"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.45in 0pt 26.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 62.95pt"></TD><TD STYLE="width: 17.9pt">(b)</TD><TD><B><I>&ldquo;Change in Control&rdquo;</I></B> means any of:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"> </FONT>any
&ldquo;person&rdquo; (as such term is defined in Section 3(a)(9) of the Securities Exchange Act of 1934, as amended (the <B><I>&ldquo;Exchange
Act&rdquo;</I></B>), and as used in Sections 13(d)(3) and 14(d)(2) of the Exchange Act) is or becomes, after the Effective Date, a
&ldquo;beneficial owner&rdquo; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the
Company representing more than fifty percent (50%) of the combined voting power of the Company&rsquo;s then outstanding securities
eligible to vote for the election of the Board (the <B><I>&ldquo;Company Voting Securities&rdquo;</I></B>) or of substantially all
of the Company&rsquo;s assets; provided, however, that an event described in this clause (i) shall not be deemed to be a Change in
Control if any of following becomes such a beneficial owner: (A) the Company or any majority-owned subsidiary (provided, that this
exclusion applies solely to the ownership levels of the Company or the majority-owned subsidiary), (B) any tax-qualified,
broad-based employee benefit plan sponsored or maintained by the Company or any majority-owned subsidiary, (C) any underwriter
temporarily holding securities pursuant to an offering of such securities, or (D) any person pursuant to a Non-Qualifying
Transaction (as defined in clause (ii));</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.7pt 0pt 26.95pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>the consummation of a merger, consolidation, statutory share exchange or similar form of corporate transaction involving the Company
or any of its subsidiaries that requires the approval of the Company&rsquo;s stockholders, whether for such transaction or the issuance
of securities in the transaction (a <B><I>&ldquo;Business Combination&rdquo;</I></B>), unless immediately following such Business Combination:
(A) more than fifty percent (50%) of the total voting power of (x) the corporation resulting from such Business Combination (the <B><I>&ldquo;Surviving
Corporation&rdquo;</I></B>), or (y) if applicable, the ultimate parent corporation that directly or indirectly has beneficial ownership
of one hundred (100%) of the voting securities eligible to elect directors of the Surviving Corporation (the <B><I>&ldquo;Parent Corporation&rdquo;</I></B>),
is represented by Company Voting Securities that were outstanding immediately prior to such Business Combination (or, if applicable, is
represented by shares into which such Company Voting Securities were converted pursuant to such Business Combination), and such voting
power among the holders thereof is in substantially the same proportion as the voting power of such Company Voting Securities among the
holders thereof immediately prior to the Business Combination, (B) no person (other than any employee benefit plan (or related trust)
sponsored or maintained by the Surviving Corporation or the Parent Corporation), is or becomes the beneficial owner, directly or indirectly,
of more than fifty percent (50%) of the total voting power of the outstanding voting securities eligible to elect directors of the Parent
Corporation (or, if there is no Parent Corporation, the Surviving Corporation) and (C) at least a majority of the members of the board
of directors of the Parent Corporation (or if there is no Parent Corporation, the Surviving Corporation) following the consummation of
the Business Combination were members of the Board as of the date hereof or at the time of the Board&rsquo;s approval of the execution
of the initial agreement providing for such Business Combination (any Business Combination which satisfies all of the criteria specified
in (A), (B) and (C) above shall be deemed to be a <B><I>&ldquo;Non-Qualifying Transaction&rdquo;</I></B>); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.25pt 0pt 26.95pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in"> (iii) &nbsp;&nbsp;&nbsp;&nbsp;the occurrence of a &ldquo;Rule 13e-3 transaction&rdquo; (as defined in Rule 13e-3 under the Exchange Act).</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.85pt 0pt 26.95pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B><I>&ldquo;Change in Control Period&rdquo;</I></B> means the period commencing 120 days prior to a Change in Control and ending
on the 24-month anniversary of such Change in Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.85pt 0pt 26.95pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B><I>&ldquo;Contemplation of a Change in Control&rdquo;</I></B> means a Covered Termination that occurs as a result of an action
directed or requested by a stockholder of the Company or any affiliate thereof, or any other person that directly or indirectly undertakes
a transaction that constitutes a Change in Control of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 37.85pt 0pt 27pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B><I>&ldquo;Covered Termination&rdquo; </I></B>means Executive&rsquo;s resignation for Good Reason or the termination of Executive&rsquo;s
employment by the Company other than a Disability Termination or a termination for Cause that, in each case and to the extent necessary,
constitutes a Separation from Service (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 46.15pt 0pt 26.95pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><B><I>&ldquo;Disability Termination&rdquo;</I></B> means a termination of employment by the Company of the Executive after the
Executive has been unable for 90 days in any 365 day period to perform his or her material duties because of physical or mental incapacity
or illness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 33.8pt 0pt 26.95pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 33.8pt 0pt 26.95pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 33.8pt 0pt 26.95pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 33.8pt 0pt 26.95pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 33.8pt 0pt 26.95pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp; </FONT><B><I>&ldquo;Good
Reason&rdquo; </I></B>means the occurrence, without Executive&rsquo;s prior written consent, of any of the following: (i) a
reduction in Executive&rsquo;s base compensation or target bonus opportunity, (ii) a material diminution in Executive&rsquo;s job
responsibilities, title, reporting relationship, duties or authorities, including without limitation if following a Change in
Control, Executive does not continue as in the same position and with the same duties, authority and compensation of the surviving
entity, (iii) a material change of at least thirty (30) miles in the geographic location at which Executive must regularly perform
Executive&rsquo;s service, (iv) any material breach by the Company of any material provision of this Agreement or any material
provision of any other agreement between the Executive and the Company, (v) the Company&rsquo;s failure to obtain an agreement from
any successor to the Company to assume and agree to perform this Agreement in the same manner and to the same extent that the
Company would be required to perform if no succession had taken place, or (vi) the Company&rsquo;s failure to nominate the Executive
for election to the Board and to use its best efforts to have him elected and re-elected, as applicable. Notwithstanding the
foregoing, Executive shall not be deemed to have &ldquo;Good Reason&rdquo; unless: (x) the condition giving rise to such resignation
continues more than thirty (30) days following Executive&rsquo;s providing to the Company a written notice of detailing such
condition, (y) such written notice is provided to the Company within ninety (90) days of the initial occurrence of such condition
and (z) Executive&rsquo;s resignation is effective within thirty (30) days following the expiration of the Company cure period
pursuant to subclause (x).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.55pt 0pt 26.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 63pt"></TD><TD STYLE="width: 17.9pt">(h)</TD><TD><B><I>&ldquo;Termination Date&rdquo;</I></B> means the date Executive experiences a Covered Termination.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 17.95pt">10.</TD><TD><U>Assignment and Successors.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.8pt 0pt 27pt; text-indent: 17.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">The Company may assign its rights
and obligations under this Agreement to any successor to all or substantially all of the business or the assets of the Company (by merger
or otherwise). This Agreement shall be binding upon and inure to the benefit of the Company, Executive and their respective successors,
permitted assigns, personnel and legal representatives, executors, administrators, heirs, distributees, devisees, and legatees, as applicable.
None of Executive&rsquo;s rights or obligations may be assigned or transferred by Executive, other than Executive&rsquo;s rights to payments
hereunder, which may be transferred only by will or operation of law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.8pt 0pt 27pt; text-indent: 17.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 17.95pt">11.</TD><TD><U>Notices.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: 17.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">Any notice, request, claim, demand,
document and other communication hereunder to any party shall be effective upon receipt (or refusal of receipt) and shall be in writing
and delivered personally or sent by facsimile or certified or registered mail, postage prepaid (or if it is sent through any other method
agreed upon by the parties), as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: 17.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 80.95pt"></TD><TD STYLE="width: 17.9pt">(i)</TD><TD STYLE="padding-right: 348.45pt">if to the Company:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 348.45pt 0pt 98.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 348.45pt 0pt 98.95pt">Inseego Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 98.95pt">Attn: Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287.3pt 0pt 99pt">9710 Scranton Road, Suite 200 San Diego, CA 92121</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 81pt"></TD><TD STYLE="width: 17.85pt">(ii)</TD><TD>if to Executive, at the address set forth in Executive&rsquo;s personnel file with the Company; or</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 81pt"></TD><TD STYLE="width: 17.75pt">(iii)</TD><TD>at any other address as any party shall have specified by notice in writing to the other party.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 17.95pt">12.</TD><TD><U>Non-Disparagement.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.55pt 0pt 27pt; text-indent: 17.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.25in">Executive agrees that he or she
shall not disparage, criticize or defame the Company, its affiliates and their respective affiliates, directors, officers, agents, partners,
stockholders or employees, either publicly or privately, except in the reasonable good faith performance of his duties to the Company,
and the Company agrees that neither the Company, its officers, directors or employees, nor anyone acting on its or their behalf, will
either publicly or privately, except in the reasonable good faith performance of their respective duties to the Company, disparage, criticize
or defame Executive. Nothing in this Section 12 shall have application to any evidence, testimony or disclosure required by any court,
arbitrator or government agency. Nothing in this Agreement (a) prevents Executive from discussing or disclosing information about unlawful
acts in the workplace, such as harassment or discrimination or any other conduct that Employee has reason to believe is unlawful or (b)
in any way otherwise restricts or impedes the Executive from exercising protected rights to the extent that such rights cannot be waived
by agreement or from complying with any applicable law or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.55pt 0pt 27pt; text-indent: 17.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 17.95pt">13.</TD><TD><U>Dispute Resolution.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.7pt 0pt 26.95pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Scope</U>. Except for Excluded Claims (as defined below in Section 13(h)), any and all claims, actions, disputes, grievances,
complaints, charges, or allegations (collectively, &ldquo;<B><I>Claims</I></B>&rdquo;; individually, a &ldquo;<B><I>Claim</I></B>&rdquo;)
arising out of, relating to, or regarding the terms of this Agreement, Executive&rsquo;s employment with the Company, the separation of
Executive&rsquo;s Employment with the Company, or the Executive&rsquo;s relationship with the Company shall be subject to arbitration
in San Diego County, California before American Arbitration Association (&ldquo;<B><I>AAA</I></B>&rdquo;), pursuant to the then- existing
AAA Employment Arbitration Rules and Mediation Procedures (the &ldquo;<B><I>AAA Rules</I></B>&rdquo;). The parties can obtain a copy of
the AAA Rules (i) on the AAA&rsquo;s website (https://www.adr.org/employment) or (ii) by
calling AAA directly at (800) 778-7879. The AAA Rules are incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.7pt 0pt 26.95pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Arbitrability</U>. To the extent provided by law, the arbitrator, not a court, will determine issues of arbitrability or waiver
of arbitrability. The parties waive any right to have a court determine issues of arbitrability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55in 0pt 27pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Arbitrator&rsquo;s Authority</U>. The arbitration must be commenced by a written demand for arbitration containing the same
detailed statement of facts as if the initiating party was filing a complaint in court. The arbitration will be before a neutral arbitrator,
who shall have the power to decide, among other things, any motions brought by any party, including discovery motions, motions for sanctions,
motions for summary judgment and/or adjudication, motions to dismiss, and demurrers, applying the standards set forth under the California
Code of Civil Procedure. The arbitrator will grant an award of costs in connection with an offer by a Party to compromise pursuant to
California Code of Civil Procedure section 998 or an offer of judgement pursuant to Federal Rule of Civil Procedure 68. The arbitrator
may also grant injunctions and all other types of relief the parties would otherwise be available in court. Although the parties shall
be entitled to more than minimal discovery; however, the arbitrator also shall have the authority to order discovery, by way of deposition,
interrogatory, document production, or otherwise, as the arbitrator considers necessary to a full and fair exploration of the issues in
dispute, consistent with the expedited nature of arbitration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.45pt 0pt 27pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Timing</U>. The arbitrator shall issue the arbitration decision (and, if applicable, award) within 180 days of a Party initiating
arbitration as set forth in this Section 13 or an order compelling any Covered Claim to arbitration under this Agreement. Notwithstanding
the 180-day in this Section 13(c), the arbitrator may extend the 180-day deadline set forth in this Section 13(c) only if: (i) the parties
stipulate in a signed writing to an extension or (ii) the arbitrator finds that there are extenuating circumstances to extend the 180-day
deadline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.65pt 0pt 26.95pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Final and Binding Arbitration</U>. The arbitrator shall issue a written final decision or award on the merits. The parties agree
that the decree or award rendered by the arbitrator may be entered as a final and binding judgment in any court having jurisdiction thereof.
The parties further agree that that the prevailing party in any arbitration shall be entitled to injunctive relief in any court of competent
jurisdiction to enforce the arbitration award. The parties also agree that by entering into this Agreement, the parties are giving up
their constitutional right to have a trial by jury and giving up the parties&rsquo; normal rights of appeal following the rendering of
a decision, except as applicable law provides for judicial review of arbitration proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.15pt 0pt 27pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.15pt 0pt 27pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.15pt 0pt 27pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.15pt 0pt 27pt; text-indent: 35.95pt"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.15pt 0pt 27pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Injunctive Relief</U>. Notwithstanding the foregoing, this Section 13 will not prevent either party from seeking injunctive
relief (or any other provisional remedy) from any court having jurisdiction over the parties and the subject matter of their Claim relating
to this Agreement and the agreements incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 40.9pt 0pt 27pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U>Class
Action Waiver</U>. Except for Excluded Claims (as defined below in Section 13(h)), the parties intend and agree that (i) class
action, collective action, and representative action procedures are hereby waived and shall not be asserted, nor will they apply, in
any arbitration pursuant to this Agreement; (ii) each party will not assert class action, collective action, or representative
action claims against the other party in arbitration or otherwise; and (iii) the parties shall only submit their own, individual
Claims in arbitration and will not seek to represent the interests of any other Person. To the extent the parties&rsquo; Claims
involve both timely filed Excluded Claims and Claims subject to arbitration under this Agreement, the parties agree to stay any such
Excluded Claims for the duration of the arbitration proceedings relating to the Claims subject to arbitration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.3pt 0pt 27pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U>Excluded
Claims</U>. &ldquo;<B><I>Excluded Claims</I></B>&rdquo; are causes of action or claims: (i) under the National Labor Relations Act;
(ii) that constitute non-individual actions under the California Private Attorneys General Act (&ldquo;<B><I>PAGA</I></B>&rdquo;),
unless applicable laws (whether now or in the future) permit such PAGA claims to be subject to arbitration; (iii) under the
California Workers&rsquo; Compensation Act; (iv) for unemployment compensation benefits; (v) for benefits under a plan that is
governed by the Employee Retirement Income Security Act of 1974; (vi) subject to the Ending Forced Arbitration of Sexual Assault and
Sexual Harassment Act; or (vii) that are expressly prohibited from mandatory arbitration under applicable law. To the extent
Employee brings, asserts, or raises a PAGA Claim against the Company, the Parties agree that Employee&rsquo;s non-individual PAGA
Claim must be stayed pending the outcome of the arbitration of the individual PAGA Claim pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.7pt 0pt 26.95pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Arbitration Costs and Fees</U>. With respect to costs associated with and unique to arbitration under this Section 13, Executive
shall only pay the AAA filing or administrative fee up to the equivalent amount of the initial filing Employee would have paid to commence
an action in the California Superior Court, County of San Diego. The Company will pay any other AAA administrative fees, arbitrator&rsquo;s
fees, and any additional fees unique to arbitration within 30 days after the due date of such fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 36.05pt 0pt 27pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(j)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Attorneys&rsquo; Fees</U>. If Executive&rsquo;s Termination Date occurs within a Change in Control Period, the Company shall
pay on Executive&rsquo;s behalf or reimburse to Executive promptly (in no event later than 30 days after the invoice date) all reasonable
costs and expenses (including fees and disbursements of counsel) incurred by Executive in seeking to enforce rights pursuant to this Agreement,
whether or not Executive is successful in asserting such rights; provided, that no reimbursement shall be made of such expenses relating
to any unsuccessful assertion of rights if and to the extent that Executive&rsquo;s assertion of such rights was in bad faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 36.55pt 0pt 27pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Operative Arbitration Agreement</U>. Should any part of this Section 13 conflict with any other arbitration agreement between
the Parties, whether written, oral, or implied, the Parties agree that this Section 13 in this Agreement shall govern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.85pt 0pt 27pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.85pt 0pt 27pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.85pt 0pt 27pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.85pt 0pt 27pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.85pt 0pt 27pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.85pt 0pt 27pt; text-indent: 35.95pt"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.85pt 0pt 27pt; text-indent: 35.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 44.95pt"></TD><TD STYLE="width: 17.95pt">14.</TD><TD><U>Miscellaneous Provisions.</U></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 63pt"></TD><TD STYLE="width: 17.9pt">(a)</TD><TD><U>Section 409A</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.25pt 0pt 27pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 27pt; text-indent: 0.75in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Separation from Service</U>. Notwithstanding any provision to the contrary in this Agreement, no amount deemed deferred compensation
subject to Section 409A of the Code shall be payable pursuant to Sections 3, 4 or 5 above unless Executive&rsquo;s termination of employment
constitutes a &ldquo;separation from service&rdquo; with the Company within the meaning of Section 409A of the Code and the Department
of Treasury regulations and other guidance promulgated thereunder (<B><I>&ldquo;Separation from Service&rdquo;</I></B>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.25pt 0pt 27pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 27pt; text-indent: 0.75in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp; </FONT><U>Specified
Employee</U>. Notwithstanding any provision to the contrary in this Agreement, if Executive is deemed at the time of his or her
separation from service to be a &ldquo;specified employee&rdquo; for purposes of Section 409A(a)(2)(B)(i) of the Code, to the extent
delayed commencement of any portion of the benefits to which Executive is entitled under this Agreement is required in order to
avoid a prohibited distribution under Section 409A(a)(2)(B)(i) of the Code, such portion of Executive&rsquo;s benefits shall not be
provided to Executive prior to the earlier of (A) the expiration of the six (6)-month period measured from the date of
Executive&rsquo;s Separation from Service or (B) the date of Executive&rsquo;s death. Upon the first business day following the
expiration of the applicable Code Section 409A(a)(2)(B)(i) period, all payments deferred pursuant to this Section 14(a)(ii) shall be
paid in a lump sum to Executive, and any remaining payments due under this Agreement shall be paid as otherwise provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.65pt 0pt 26.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 27pt; text-indent: 0.75in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;
</FONT><U>Expense Reimbursements</U>. To the extent that any reimbursements payable pursuant to this Agreement are subject to the provisions
of Section 409A of the Code, any such reimbursements payable to Executive pursuant to this Agreement shall be paid to Executive no later
than December 31 of the year following the year in which the expense was incurred, the amount of expenses reimbursed in one year shall
not affect the amount eligible for reimbursement in any subsequent year, and Executive&rsquo;s right to reimbursement under this Agreement
will not be subject to liquidation or exchange for another benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4in 0pt 27pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 27pt; text-indent: 0.75in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp; </FONT><U>Release</U>.
Notwithstanding anything to the contrary in this Agreement, to the extent that any payments due under this Agreement as a result of
Executive&rsquo;s termination of employment are subject to Executive&rsquo;s execution and delivery of a Release of Claims, (A) the
Company shall deliver the Release of Claims to Executive within ten (10) business days following the Termination Date, (B) if
Executive fails to execute the Release of Claims on or prior to the Release Expiration Date (as defined below) or timely revokes his
or her acceptance of the Release of Claims thereafter, Executive shall not be entitled to any payments or benefits otherwise
conditioned on the Release of Claims, and (C) in any case where the Termination Date and the Release Expiration Date fall in two
separate taxable years, any payments required to be made to Executive that are conditioned on the Release of Claims and are treated
as nonqualified deferred compensation for purposes of Section 409A shall be made in the later taxable year. For purposes of this
Section 14(a)(iv), <B><I>&ldquo;Release Expiration Date&rdquo;</I></B> shall mean the date that is forty-five (45) days following
the date upon which the Company timely delivers the Release of Claims to Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.55pt 0pt 27pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Withholding</U>. The Company shall be entitled to withhold from any amounts payable under this Agreement any federal, state,
local or foreign withholding or other taxes or charges which the Company is required to withhold. The Company shall be entitled to rely
on an opinion of counsel if any questions as to the amount or requirement of withholding shall arise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 34.65pt 0pt 27pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Amendment; Waiver</U>. This Agreement may not be modified, amended, or terminated except by an instrument in writing, signed
by Executive and a member of the Board or a Company officer designated by the Board. No waiver shall operate as a waiver of, or estoppel
with respect to, any other or subsequent failure. No failure to exercise and no delay in exercising any right, remedy, or power hereunder
preclude any other or further exercise of any other right, remedy, or power provided herein or by law or in equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 42.55pt 0pt 27pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 42.55pt 0pt 27pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 42.55pt 0pt 27pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 42.55pt 0pt 27pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 42.55pt 0pt 27pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Entire Agreement</U>. The terms of this Agreement, collectively with the Inventions, Disclosure, Confidentiality &amp; Proprietary
Rights Agreement between the Company and Executive entered into on or about the date herewith (the <B><I>&ldquo;Confidentiality Agreement&rdquo;</I></B>),
and the Indemnification Agreement, is intended by the Parties to be the final expression of their agreement with respect to the employment
of Executive by the Company and supersede all prior understandings and agreements (but not the Confidentiality Agreement or the Indemnification
Agreement), whether written or oral. The parties further intend that this Agreement, collectively with the Confidentiality Agreement,
and the Indemnification Agreement, shall constitute the complete and exclusive statement of their terms and that no extrinsic evidence
whatsoever may be introduced in any judicial, administrative, or other legal proceeding to vary the terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.9pt 0pt 27pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Choice of Law</U>. The validity, interpretation, construction and performance of this Agreement shall be governed by the laws
of the State of California.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 37.3pt 0pt 27pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Severability</U>. The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity
or enforceability of any other provision hereof, which shall remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 34.25pt 0pt 27pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Counterparts</U>. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which
together will constitute one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 48.6pt 0pt 27pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 27pt; text-indent: 17.95pt">IN WITNESS WHEREOF, each of the
parties has executed this Agreement, in the case of the Company by its duly authorized officer, as of the day and year set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">&nbsp;</TD>
  <TD STYLE="width: 50%"><B>INSEEGO CORP.</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>By:________________________________</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Title: _______________________________</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Date:</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD><B>EXECUTIVE</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>____________________________________</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>JUHO SARVIKAS</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Date: ________________, 20__</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U>Exhibit A</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">FORM OF RELEASE AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">CONSIDERATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 37.1pt 0pt 32pt; text-indent: 35.85pt">This release is given in consideration
of the severance benefits described on <U>Schedule 1</U>. I understand that because the Company has no policy obligating it to pay severance
to terminated employees, and because my Change in Control and Severance Agreement dated January [<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT>],
2025 (the &ldquo;Severance Agreement&rdquo;) conditions payment of severance benefits and certain other rights and benefits on a Release
of Claims, the benefits provided to me under this agreement constitute consideration for which I would not otherwise be eligible unless
I elect to sign this Release Agreement. I understand and agree that this Release Agreement is not given in return for the payment of any
wages otherwise due. I also understand that if I revoke this release after signing, I will not be entitled to the severance benefits described
in the Severance Agreement or this release. I understand that if I do not return a signed copy of this Release Agreement to the Company
within 21 days of receipt, the offer under this Release Agreement will expire and I will not be eligible for any of the severance set
forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 37.1pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">RELEASE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50pt"><U>Released Claims</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 36.25pt 0pt 32pt; text-indent: 35.85pt">In exchange for the above-referenced
severance, I, on behalf of my heirs, spouse, successors and assigns, hereby completely release and forever discharge the Company, its
past and present parent companies, subsidiaries, affiliates, related entities, and each of their past and present agents, officers, directors,
shareholders, employees, attorneys, insurers, successors and assigns (collectively referred to as &quot;Releasees&quot;) from any and
all claims, demands, actions, causes of actions, judgements, rights, fees, damages, debts, obligations, liabilities and expenses (collectively,
&ldquo;Claims&rdquo;), of any and every kind, nature and character, known or unknown, foreseen or unforeseen, based on any act or omission
occurring prior to the date of my signing this Release Agreement, to the fullest extent allowed by law, including but not limited to any
Claims arising out of my offer of employment, my employment, or the termination or separation of my employment with the Company. The matters
released include, but are not limited to,any Claims under federal, state or local employment, wage and hour, discrimination and other
statutes or regulations, including Claims arising under Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, Section
1981 of Title 42, the Fair Credit Reporting Act, the Americans with Disabilities Act, the Family and Medical Leave Act, the California
Fair Employment and Housing Act, the California Labor Code, the Age Discrimination in Employment Act of 1967 (&quot;ADEA&quot;), all including
any amendments and their respective implementing regulations, and any other federal state, local or foreign law (statutory, regulatory,
or otherwise) that may be legally waived and released, and any common law tort, contract or statutory claims, and any Claims for attorneys&rsquo;
fees and costs; however the identification of specific statutes is for purposes of example only, and the omission of any specific statute
or law shall not limit the scope of this general release in any manner. Notwithstanding the foregoing, nothing in this Release is intended
to waive or release Claims that may not be legally waived under applicable law, including claims challenging the validity of this Release
Agreement under the ADEA, claims for unemployment benefits or benefits under workers' compensation laws, my right to receive any equity
or retirement benefits that are vested as of the date my employment terminates, or my rights and benefits pursuant to the terms of the
Severance Agreement and this release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 36.25pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 36.25pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 36.25pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 36.25pt 0pt 32pt; text-indent: 35.85pt"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 36.25pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 46.15pt 0pt 32pt; text-indent: 35.85pt">I understand and agree the above
release extinguishes all Claims, whether known or unknown, foreseen or unforeseen. I expressly waive any rights or benefits under Section
1542 of the California Civil Code, or any equivalent statute. California Civil Code Section 1542 provides as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 46.15pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 105.15pt 0pt 68pt; text-indent: 17.95pt">&quot;A GENERAL RELEASE DOES
NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING
THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.&quot;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.45in 0pt 32pt; text-indent: 35.85pt">I understand that, if any fact
with respect to any matter covered by this Release Agreement is later found to be other than or different from the facts now believed
by me to be true, this Release Agreement shall still be effective, notwithstanding such difference in the facts or my understanding of
the facts and I waive any and all Claims that might arise as a result of such different or additional facts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.45in 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50pt"><U>Enforcement of This Release Agreement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 32pt; text-indent: 35.85pt">I also understand and agree that
if any suit, affirmative defense, or counterclaim is brought to enforce the provisions of this Release Agreement (with the exception of
a claim brought by me challenging the validity of this Release Agreement under the ADEA), the prevailing party shall be entitled to its
costs, expenses, and attorneys&rsquo; fees as well as any and all other remedies authorized under the law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50pt"><U>Covenant Not to Sue</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.55pt 0pt 32pt; text-indent: 35.85pt">I agree not to pursue any action
nor seek damages or any other remedies for any claims released under this Release Agreement. I agree to execute any and all documents
necessary to request dismissal or withdrawal, or to opt-out, of such claims with prejudice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.55pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50pt"><U>Non-Disparagement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 39.95pt 0pt 32pt; text-align: justify; text-indent: 35.85pt">I agree not
to at any time make, publish, or communicate to any person or entity or in any public forum any defamatory, maliciously false, or disparaging
remarks, comments, or statements concerning the Company or its businesses, or any of its employees, officers, or directors, now or in
the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 39.95pt 0pt 32pt; text-align: justify; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 46.15pt 0pt 32.05pt; text-indent: 35.85pt">This Section does not, in any
way, restrict or impede me from exercising protected rights to the extent that such rights cannot be waived by agreement or from complying
with any applicable law or regulation or a valid order of a court of competent jurisdiction or an authorized government agency, provided
that such compliance does not exceed that required by the law, regulation, or order. I will promptly provide written notice of any such
order to the Company&rsquo;s Chief Administrative Officer &amp; General Counsel at 9710 Scranton Road, Suite 200, San Diego, California
92121. Additionally, nothing in this Release Agreement prevents me from discussing or disclosing information about unlawful acts in the
workplace, such as harassment or discrimination or any other conduct that I have reason to believe is unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 46.15pt 0pt 32.05pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50pt"><U>Miscellaneous</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.45in 0pt 32pt; text-indent: 35.85pt">I further acknowledge that during
my employment, I may have obtained confidential, proprietary and trade secret information, including information relating to the Company's
products, plans, designs and other valuable confidential information. I agree not to use or disclose any such confidential information
unless required by subpoena or court order, and that I will first give the Company written notice of such subpoena or court order with
reasonable advance notice to permit the Company to oppose such subpoena or court order if it chooses to do so. In addition, any prior
agreements between me and the Company with respect to such confidential or trade secret information remain in force and effect following
the termination of my employment and acceptance of this Release Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.45in 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.45in 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.45in 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.45in 0pt 32pt; text-indent: 35.85pt"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.45in 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 63.8pt 0pt 32pt; text-indent: 35.85pt">Notwithstanding any provision herein,
pursuant to the Defend Trade Secrets Act, 18 U.S.C. section 1833(b), I understand that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 63.8pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 40.65pt 0pt 32pt; text-indent: 35.85pt">An individual shall not be held
criminally or civilly liable under Federal or State trade secret law for the disclosure of a trade secret that: (a) is made (i) in confidence
to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of
reporting or investigating a suspected violation of law; or (b) is made in a complaint or other proceeding, if such filing is made under
seal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 40.65pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 37.6pt 0pt 32pt; text-indent: 35.85pt">Further, an individual who files
a lawsuit for retaliation or reporting a suspected violation of law may disclose the Company&rsquo;s trade secrets to the attorney and
use the trade secret information in the court proceeding if the individual: (a) files any document containing the trade secret under seal;
and (b) does not disclose the trade secret, except pursuant to court order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 37.6pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 42.75pt 0pt 32.05pt; text-align: justify; text-indent: 35.85pt">I will
return to the Company, within ten (10) days following the date I return this signed Release Agreement to the Company, all Company property,
including computers and peripherals, hot spots, cell phones, devices, tablets, keys, credit cards, files, flash drives, and other property
of the Company I received during my employment that is in my possession or control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 42.75pt 0pt 32.05pt; text-align: justify; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.65pt 0pt 32pt; text-indent: 35.85pt">I agree and covenant not to use
any of the Company&rsquo;s trade secrets and/or confidential information to directly or indirectly solicit employees of the Company. The
Company and I agree that the provisions of this paragraph contain restrictions that are not greater than necessary to protect the interests
of the Company. In the event of the breach or threatened breach by me of this paragraph, the Company, in addition to all other remedies
available to it at law or in equity, will be entitled to seek injunctive relief and/or specific performance to enforce this Release Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.65pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 46.15pt 0pt 32pt; text-indent: 35.85pt">I specifically agree and acknowledge
that: (i) I have read this Release Agreement in its entirety and understand all of its terms; (ii) I knowingly, freely, and voluntarily
assent to all of this Release Agreement&rsquo;s terms and conditions including, without limitation, the waivers, releases, and covenants
contained in it; (iii) I am signing this Release Agreement, including the release, in exchange for good and valuable consideration in
addition to anything of value to which I am otherwise entitled; (iv) I am not waiving or releasing rights or claims that may arise after
I sign this Release Agreement; and (v) I understand that the waivers and releases in this Agreement are being requested in connection
with the separation of employment from the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 46.15pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 46.15pt 0pt 32pt; text-indent: 35.85pt">I specifically represent, warrant,
and confirm that I: (i) have not filed any claims, complaints, or actions of any kind against the Company with any federal, state, or
local court or government or administrative agency; (ii) have not made any claims or allegations to the Company related to sexual harassment,
sex discrimination, or sexual abuse, and that none of the payments set forth in this Agreement are related to sexual harassment, sex discrimination,
or sexual abuse; (iii) have been properly paid for all hours worked for the Company; (iv) have received all wages, salary, commissions,
bonuses, and other compensation due to, including my final paycheck for wages and any accrued but unused paid time off and including the
date of my termination; and (v) have not engaged in and am not aware of any unlawful conduct relating to the business of the Company.
If any of these statements is not true, I cannot sign this Release Agreement and must notify the Company immediately in writing of the
statements that are not true. This notice will not automatically disqualify me from receiving the benefits offered in this Release Agreement,
but will require the Company's further review and consideration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 46.15pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 46.15pt 0pt 32pt; text-indent: 35.85pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 37.6pt 0pt 32pt; text-indent: 35.85pt">This Release Agreement constitutes
the entire agreement between myself and the Company with respect to any matters referred to in this Release Agreement. Except for any
prior agreements relating to the confidentiality of Company information, this Release Agreement supersedes any and all of the other agreements
between myself and the Company. No other consideration, agreements, representations, oral statements, understandings or course of conduct
which are not expressly set forth in this Release Agreement should be implied or are binding. I am not relying upon any other agreement,
representation, statement, omission, understanding, or course of conduct which is not expressly set forth in this Release Agreement. I
understand and agree that this Release Agreement shall not be deemed or construed at any time or for any purposes as an admission of any
liability or wrongdoing by either myself or the Company. I also agree that if any provision of this Release Agreement is found by a court
of competent jurisdiction to be invalid, illegal, or unenforceable in any respect, or enforceable only if modified, such finding shall
not affect the validity of the remainder of this Release Agreement, which shall remain in full force and effect and continue to be binding
on the parties hereto. The terms and conditions of this Release Agreement will be interpreted and construed in accordance with the laws
of California.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 37.6pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 37.6pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 37.6pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 37.6pt 0pt 32pt; text-indent: 35.85pt"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 37.6pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 37.1pt 0pt 32pt; text-indent: 35.85pt">I have read this Release Agreement
and understand all of its terms. Prior to execution of this Release Agreement, I have apprised myself of sufficient relevant information
in order that I might intelligently exercise my own judgment. The Company has informed me in writing to consult an attorney before signing
this Release Agreement, if I wish. The Company has given me at least <B>21 </B>days in which to consider this Release Agreement, and I
have taken as much of that 21-day period as I require to evaluate whether to sign this Release Agreement. Once this signed Release Agreement
is returned to the General Counsel of Inseego Corp. at 9710 Scranton Road, Suite 200, San Diego, CA 92121, I can revoke it by notifying
the General Counsel in writing via hand delivery, email, fax, or postmark no later than seven (7) days following my execution of this
Release Agreement. This Release Agreement shall not become effective or enforceable until such revocation period has expired.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 37.1pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 32pt; text-indent: 35.85pt">I further acknowledge and agree
that this Release Agreement is executed voluntarily and with full knowledge of its legal significance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 37.1pt 0pt 32pt; text-indent: 35.85pt">Finally, provided this Release
Agreement has not been previously publicly disclosed by the Company in filing with the Securities and Exchange Commission (&ldquo;SEC&rdquo;)
or otherwise, I agree that I will not disclose voluntarily or allow anyone else to disclose either the existence, reason for or contents
of this Release Agreement without the Company's prior written consent, unless required to do so by law or in response to an inquiry from
a government or law enforcement agency. Notwithstanding this provision, I am authorized to disclose this Release Agreement to my spouse,
attorneys and tax advisors on a &quot;need to know&quot; basis, on the condition that they agree to hold the terms of the Release Agreement,
including the settlement payments, in strictest confidence. I am further authorized to make appropriate disclosures as required by law,
provided that I notify the Company in writing of such legal obligations to disclose at least five (5) business days in advance of disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 37.1pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50pt"><U>Protected Rights</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 46.15pt 0pt 32pt; text-indent: 35.95pt">No provisions in this Release
Agreement, including the provisions addressing my Release of Claims, my Covenant Not to Sue, and/or my confidentiality obligations, are
intended to limit in any way my right or ability to file a complaint, charge or claim of discrimination with, report illegal behavior
to, or respond to any inquiries from, the Equal Employment Opportunity Commission, the National Labor Relations Board, the Department
of Labor, the SEC, the California Civil Rights Division, or any other federal, state or local government or law enforcement agency. I
understand that I retain the right to participate in any such action, inquiry or proceeding. I understand that I retain the right to communicate
with such agencies and such communication can be initiated by me or in response to an inquiry (with the understanding that any such filing
or participation does not give me the right to recover any monetary damages against the Company; my release of claims herein bars me from
recovering such monetary relief from the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 46.15pt 0pt 32pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 41pt 0pt 32pt; text-indent: 35.85pt">Notwithstanding the above, unless
otherwise prohibited by law, by signing this Release Agreement I release and waive my right to claim or recover, share or participate
in, monetary damages from the Company in any charge, complaint, or lawsuit filed by me, by such agencies, or by anyone else on my behalf,
for any released claims resulting from any of the above proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 41pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 32pt; text-indent: 35.85pt">Further, I understand that claims
challenging the validity of this release agreement under the ADEA as amended by the Older Workers Benefit Protection Act (OWBPA) are not
released.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 32pt; text-indent: 35.85pt"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 32pt; text-indent: 35.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.8pt 0pt 17.75pt; text-align: center"><U>EMPLOYEE'S ACCEPTANCE OF RELEASE</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 39pt 0pt 32pt; text-align: justify; text-indent: 35.85pt">I HAVE CAREFULLY
READ AND FULLY UNDERSTAND AND VOLUNTARILY AGREE TO ALL THE TERMS OF THE RELEASE IN EXCHANGE FOR THE ADDITIONAL BENEFITS TO WHICH I WOULD
OTHERWISE NOT BE ENTITLED.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">&nbsp;</TD>
  <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-left: 20pt">Dated:___________________</TD>
  <TD>__________________________________</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">JUHO SARVIKAS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>
</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>AFFIRMED AND AGREED TO BY INSEEGO CORP.:</B></TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>By: ______________________________________</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Name: ____________________________________</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Title: _____________________________________</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Date: _____________________________________</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><IMG SRC="image_002.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B><U>Schedule 1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Provided that the Release Agreement
has become effective and not been revoked, the following severance benefits will be provided:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[INSERT SPECIFICS OF SEVERANCE
BENEFITS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.05pt 0pt 29.8pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center"><U>EXHIBIT B</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">INSEEGO CORP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 18.8pt 0pt 17.75pt; text-align: center; text-indent: 0in">Inducement
Performance Restricted Stock Unit Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 31.3pt 0pt 27pt; text-indent: 0.5in">Inseego Corp., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), hereby grants Stock Units to the individual named below (the &ldquo;<U>Grantee</U>&rdquo;). The terms
and conditions of the Stock Units are set forth in the attached Stock Unit Award Agreement (&ldquo;<U>Award Agreement</U>&rdquo; or &ldquo;<U>Award</U>&rdquo;).
&ldquo;<U>Unit</U>&rdquo; or &ldquo;<U>Stock Unit</U>&rdquo; means the contingent right to receive the equivalent of one (1) share of
the Company&rsquo;s common stock (a &ldquo;<U>Share</U>&rdquo;), in the event the Stock Unit vests and becomes payable pursuant to the
terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt; text-indent: 0.5in">This Award constitutes a stand-alone
award, separate and apart from, and outside of, the Inseego Corp. 2018 Omnibus Incentive Compensation Plan (as amended, the &ldquo;<U>Plan</U>&rdquo;)
and shall not constitute an award granted under or pursuant to the Plan. This Award is intended to constitute an &ldquo;employment inducement
grant&rdquo; under Rule 5635(c)(4) of the Nasdaq Listing Rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border: black 1pt solid; padding-left: 2.95pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name of Recipient</FONT></TD>
    <TD COLSPAN="6" STYLE="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Juho Sarvikas</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 2.95pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Target Award</FONT></TD>
    <TD COLSPAN="6" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt">The target number of Shares that may be earned under this Agreement
    as set forth</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt">in the Payout Matrix, which number is [&#9679;]1
    Shares.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 2.95pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Maximum Award</FONT></TD>
    <TD COLSPAN="6" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">The maximum number of Shares that may be earned under this Agreement as set forth in the Payout Matrix, which number represents 200% of the Target Award.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 2.95pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Purchase Price per Share (if applicable)</FONT></TD>
    <TD COLSPAN="6" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Not applicable.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 2.95pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Date of Grant</FONT></TD>
    <TD COLSPAN="6" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">January [&#9679;], 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 2.95pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Measurement Date</FONT></TD>
    <TD COLSPAN="6" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">January [&#9679;], 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 2.95pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Performance Period</FONT></TD>
    <TD COLSPAN="6" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">January [&#9679;], 2025 through and including January [&#9679;], 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 2.95pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Performance Vesting</FONT></TD>
    <TD COLSPAN="6" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid">
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 3pt">Subject to the terms of the Change in Control Agreement,
    Stock Units will be earned and vest on the Measurement Date, based upon on the performance of the Company&rsquo;s Common Stock (INSG)
    relative to the total shareholder return of Russell Microcap Index (&ldquo;rTSR&rdquo;) during the Performance Period. The Company&rsquo;s
    rTSR shall be determined based on the weighted-average closing price of Inseego&rsquo;s common stock for the period of December 9, 2024
    through January 3, 2025 (the &ldquo;Beginning Stock Price&rdquo;) and the 30-day average closing price of Inseego&rsquo;s common stock
    prior to January [&#9679;], 2028 (&ldquo;Ending Stock Price&rdquo;).</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt">Cumulative rTSR shall be calculated as follows:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt">(Ending Stock Price minus Beginning Stock Price plus dividends)
    divided by</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt">Beginning Stock Price)</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="3" STYLE="width: 31%; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 2.95pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Payout Matrix</FONT></TD>
    <TD STYLE="width: 20%; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-left: 8.6pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">rTSR percentile for INSG</FONT></TD>
    <TD STYLE="width: 8%; border-bottom: black 1pt solid; border-right: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35pt; text-align: center">&lt;40%</P></TD>
    <TD STYLE="width: 9%; border-bottom: black 1pt solid; border-right: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: center">40%</P></TD>
    <TD STYLE="width: 9%; border-bottom: black 1pt solid; border-right: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45pt; text-align: center">50%</P></TD>
    <TD STYLE="width: 10%; border-bottom: black 1pt solid; border-right: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.05pt; text-indent: 0.45pt">(Target</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.7pt; text-indent: -5.65pt">Award) 60%</P></TD>
    <TD STYLE="width: 13%; border-bottom: black 1pt solid; border-right: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0; text-align: center">(Maximum</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10.25pt 0pt 7.5pt; text-align: center">Award) 80%</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.6pt">Stock Units Earned</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.6pt">as a Percentage of Target Award</P></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0.35pt; text-align: center">0</P></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: center">30%</P></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45pt; text-align: center">40%</P></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt">100%</P></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">200%</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="6" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt">If performance is between two thresholds, the percentage of
    the Award earned will be interpolated on a straight-line basis.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 18.8pt 0pt 17.75pt; text-align: center">[SIGNATURE PAGE FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0"></P>

<P STYLE="margin: 0pt 0">___________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 30.05pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">1</FONT>
The number of shares shall be determined by dividing $1,800,000 by the weighted-average closing price of Inseego&rsquo;s common stock
for the period of December 9, 2024 through January 3, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: -0.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: -0.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: -0.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: -0.05pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: -0.05pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: -0.05pt"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: -0.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 26.95pt; text-indent: 35.95pt">BY ACCEPTING THIS STOCK UNIT
GRANT, you and the Company agree that the Stock Units are hereby awarded under and governed by the terms and conditions of this Stock
Unit Grant, and the attached Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">INSEEGO CORP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 14%; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: left; width: 33%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 53%; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B><U>Grantee</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 14%; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 33%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 53%; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 3pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Juho Sarvikas</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">INSEEGO CORP.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 40%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 18.8pt 0pt 17.75pt; text-align: center; text-indent: 0in">Inducement
Restricted Stock Unit Award Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 44.95pt"></TD><TD STYLE="width: 18pt">1.</TD><TD STYLE="text-align: justify"><B><U>Other Agreements</U></B>. The Stock Unit Grant and this Award Agreement constitute the entire
understanding between you and the Company regarding these Stock Units. Any prior agreements, commitments or negotiations concerning these
Stock Units are hereby superseded entirely. Notwithstanding the foregoing, to the extent that certain Change in Control and Severance
Agreement dated January [&#9679;], 2025 between you and the Company (the &ldquo;Change in Control Agreement&rdquo;) or any other written
employment agreement, change-in-control agreement, severance agreement or other similar written agreement or arrangement (any such arrangement,
an &ldquo;<U>Employment Arrangement</U>&rdquo;) provides for greater benefits to you than provided in the Stock Unit Grant or this Award
Agreement with respect to these Stock Units, including with respect to vesting of the Stock Units upon termination of employment or in
the event of a Change in Control, then the terms of the Employment Arrangement with respect to these matters shall supersede the terms
of the Stock Unit Grant and this Award Agreement.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 28.65pt">&nbsp;</TD></TR>
                                                           </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">2.</TD><TD STYLE="text-align: justify"><B><U>Termination of Service; Leaves of Absence</U></B>. In the event of a Covered Termination (as
that term is defined in the Change in Control Agreement) all Stock Units shall immediately become earned and fully vested with respect
to that number of Stock Units that would have vested if the Termination Date (as that term is defined in the Change in Control Agreement)
was treated as the Measurement Date and the Performance Period was January [&#9679;], 2025 through and including the Termination Date.
In the event of a termination of your service to the Company or any Subsidiary or Affiliate thereof that is not a Covered Termination,
subject to Section 1 above, this Award shall be canceled and become automatically null and void immediately upon termination of your service
to the Company or its Subsidiary or Affiliate for any reason, but only to the extent you have not earned and become vested, pursuant to
the foregoing terms, on or at the time your service to the Company or any Subsidiary or Affiliate thereof ends. For purposes of the Award,
your service is not interrupted or terminated when you go on a leave of absence that is approved in writing by a duly constituted officer
of the Company or any Subsidiary or Affiliate thereof. Your service terminates in any event when the approved leave ends unless you immediately
return to active work at the Company or any Subsidiary or Affiliate thereof. The Company, in its sole discretion, determines which leaves
count for this purpose, as well as the point in time your service terminates for all purposes under this Agreement.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 29.75pt">&nbsp;</TD></TR>
                                                                                                                             </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">3.</TD><TD STYLE="text-align: justify"><B><U>Change in Control</U></B>. In the event of a Change in Control (as that term is defined in the
Change in Control Agreement) that occurs prior to January [&#9679;], 2028, the closing date of the Change in Control shall be considered
the Measurement Date and the Ending Stock Price shall be based on the value received by the Company&rsquo;s common stockholders in connection
with the Change in Control.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 38.5pt">&nbsp;</TD></TR>
                                     </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">4.</TD><TD STYLE="text-align: justify"><B><U>Satisfaction of Vesting Restrictions</U></B>. No Shares will be issued before you complete the
requirements that are necessary for you to vest in your Stock Units. As soon as practicable after the Measurement Date, the Company will
issue to you, free from vesting restrictions (but subject to such legends as the Company determines to be appropriate), one Share for
each vested Stock Unit; <I>provided</I>, <I>however</I>, that, by accepting this Award Agreement, you authorize the Company to withhold
taxes pursuant to Section 8 below.</TD></TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">5.</TD><TD STYLE="text-align: justify"><B><U>Investment Purposes</U></B>. By accepting this Award, you represent and warrant to the Company
that any Shares issued to you pursuant to your Stock Units will be for investment for your own account and not with a view to, for resale
in connection with, or with an intent of participating directly or indirectly in, any distribution of such Shares within the meaning of
the U.S. Securities Act of 1933, as amended. You further acknowledge and agree that your ability to sell any Shares issued to you pursuant
to your Stock Units may be limited by applicable securities laws and the Company&rsquo;s Insider Trading Policy then in effect.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 28.9pt">&nbsp;</TD></TR>
                                                                                                                                         <TR STYLE="vertical-align: top">
<TD STYLE="text-align: left">&nbsp;</TD><TD>6.</TD><TD STYLE="text-align: justify"><B><U>Dividend Equivalents.</U></B> When Shares are delivered to you pursuant to the vesting of your
                                                   Stock Units, you shall also be entitled to receive, with respect to each Share issued or withheld by the Company pursuant
                                                   to<U>Section 8</U>, (a) a number of Shares equal to the per Share stock dividends which were declared and paid to the holders of
                                                   Shares between the Date of Grant and the date such Shares are delivered to you, and (b) a number of Shares having a Fair Market
                                                   Value (on the date of each cash dividend payment date) equal to any per Share cash dividends that were paid to the holders of Shares
                                                   based on a record date falling between the Date of Grant and the date such Shares are delivered to you. To the extent that your
                                                   service ends before vesting of all the Stock Units, you will forfeit all dividend equivalents (whether paid in cash or in stock)
                                                   attributable to all Shares underlying such unvested Stock Units.</TD></TR>
                                                                                                                                         <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 28.9pt">&nbsp;</TD></TR>
                                                                                                                                         </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 34.5pt 0pt 0; text-align: right"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">7.</TD><TD STYLE="text-align: justify"><B><U>Restrictions on Transfer of Award</U></B>. Your rights under this Award Agreement may not be sold,
pledged, or otherwise transferred without the prior written consent of the Board. If you attempt to do any of these things, the Stock
Units will immediately become invalid. You may, however, dispose of these Stock Units in your will. Regardless of any marital property
settlement agreement, the Company is not obligated to honor your spouse&rsquo;s interest in these Stock Units in any way.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 29.9pt">&nbsp;</TD></TR>
                                                                                                                                   </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 44.95pt"></TD><TD STYLE="width: 18pt">8.</TD><TD STYLE="text-align: justify"><B><U>Income Taxes and Deferred Compensation</U></B>. Regardless of any action the Company or your employer
(the &ldquo;<U>Employer</U>&rdquo;) takes with respect to any or all income tax, social insurance, payroll tax, payment on account or
other tax-related items related to the Stock Units and legally applicable to you (&ldquo;<U>Tax-Related Items</U>&rdquo;), you acknowledge
that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility and may exceed the amount
actually withheld by the Company or the Employer. You further acknowledge that the Company and/or the Employer (a) make no representations
or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Stock Units, including the grant
of the Stock Units, the vesting of Stock Units, the settlement of the Stock Units with Shares, the subsequent sale of any Shares acquired
at vesting and the receipt of any dividends; and (b) other than as may be set forth in the Change in Control Agreement or any other Employment
Arrangement, do not commit to structure the terms of the grant or any aspect of the Stock Units to reduce or eliminate your liability
for Tax-Related Items or achieve any particular tax result. You acknowledge that neither the Company nor the Employer shall have any obligation
to indemnify or otherwise hold you harmless from any or all of such Tax-Related Items. Further, if you are subject to tax in more than
one jurisdiction, you acknowledge that the Company and/or the Employer (or former Employer, as applicable) may be required to withhold
or account for Tax-Related Items in more than one jurisdiction.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.8pt 0pt 62.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 62.95pt">The Board shall have the sole discretion to interpret
the requirements of the U.S. Internal Revenue Code, as amended (the &ldquo;<U>Code</U>&rdquo;) for purposes of this Award Agreement. The
intent of the parties is that payments and benefits under this Award Agreement comply with Section 409A of the Code, and, accordingly,
to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith. To the extent than any provision hereof
must be modified in order to comply with Section 409A of the Code, such modification shall be made in good faith and in compliance with
the terms of the Change in Control Agreement, and shall, to the maximum extent reasonably possible, maintain the original intent and economic
benefit to you without violating the provisions of Section 409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.8pt 0pt 62.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.8pt 0pt 62.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.8pt 0pt 62.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.8pt 0pt 62.95pt"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.8pt 0pt 62.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 62.95pt">Prior to the relevant taxable or tax withholding event,
as applicable, you shall pay, or make adequate arrangements satisfactory to the Company or to the Employer (in their sole discretion)
to satisfy all Tax- Related Items. In this regard, you authorize the Company or the Employer, or their respective agents, at their discretion,
to satisfy the obligations with regard to Tax-Related Items by one or a combination of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 63pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 63pt; text-indent: 0in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>withholding a number of Shares otherwise deliverable to you from time to time equal to the Retained Share Amount (as defined below);
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 45.45pt 0pt 63pt; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 63pt; text-indent: 0in"> 2. &nbsp;withholding from your wages or other cash compensation paid to you by the Company and/or the Employer; or</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 63pt; text-indent: 0in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>withholding from proceeds of the sale of Shares acquired upon settlement of the Stock Units, either through a voluntary sale or
through a sale arranged by the Company (on your behalf pursuant to this authorization).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 52.25pt 0pt 63pt; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 62.95pt">To avoid negative accounting
treatment, the Company may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or
other applicable withholding rates. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, you
are deemed to have been issued the full number of Shares subject to the Stock Units, notwithstanding that a number of Shares is retained
solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Stock Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.75pt 0pt 62.95pt; text-indent: -0.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 62.95pt">The &ldquo;<U>Retained Share Amount</U>&rdquo; shall
mean a number of Shares equal to the quotient of the minimum statutory tax withholding obligation of the Company triggered by the vesting
of your Award on the relevant Vesting Date, divided by the Fair Market Value of one Share on the relevant Vesting Date. If the obligation
for Tax-Related Items is satisfied by withholding a number of Shares as described herein, you understand that you will be deemed to have
been issued the full number of Shares subject to the settled Stock Units, notwithstanding that a number of Shares are held back solely
for the purpose of paying the Tax-Related Items due as a result of the settlement of the Stock Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 63pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 62.95pt">You shall pay to the Company or to the Employer any
amount of Tax-Related Items that the Company or the Employer may be required to withhold as a result of your receipt of Stock Units, the
vesting of Stock Units, or the settlement of vested Stock Units with Shares that cannot be satisfied by the means previously described.
The Company may refuse to deliver Shares to you if you fail to comply with your obligation in connection with the Tax-Related Items.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 63pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">9.</TD><TD STYLE="text-align: justify"><B><U>Notices</U></B>. Any notice or communication required or permitted by any provision of this Award
Agreement to be given to you shall be in writing and shall be delivered electronically, personally, or sent by certified mail, return
receipt requested, addressed to you at the last address that the Company or the Employer had for you on its records. Each party may, from
time to time, by notice to the other party hereto, specify a new address for delivery of notices relating to this Award Agreement. Any
such notice shall be deemed to be given as of the date such notice is personally delivered or properly mailed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 63pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 62.95pt">The Company may, in its sole discretion, decide to deliver
any documents related to Stock Units by electronic means. You hereby consent to receive such documents by electronic delivery and agree
to participate in an on-line or electronic system established and maintained by the Company or another third party designated by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 63pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">10.</TD><TD STYLE="text-align: justify"><B><U>Binding Effect</U></B>. Except as otherwise provided in this Award Agreement, every covenant,
term, and provision of this Award Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective
heirs, legatees, legal representatives, successors, transferees, and assigns.</TD></TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">11.</TD><TD STYLE="text-align: justify"><B><U>Modifications</U></B>. Subject to Section 8 hereof, this Award Agreement may not be modified
or amended without your prior consent.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 56.15pt">&nbsp;</TD></TR>
                                                </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">12.</TD><TD STYLE="text-align: justify"><B><U>Headings</U></B>. Section and other headings contained in this Award Agreement are for reference
purposes only and are not intended to describe, interpret, define or limit the scope or intent of this Award Agreement or any provision
hereof.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 34.2pt">&nbsp;</TD></TR>
                 </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">13.</TD><TD STYLE="text-align: justify"><B><U>Severability</U></B>. The provisions of this Award Agreement are severable and if any one or more
provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be
binding and enforceable.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 32.1pt">&nbsp;</TD></TR>
                                  </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">14.</TD><TD STYLE="text-align: justify"><B><U>Stockholder Rights</U></B>. You, or your estate or heirs, have no rights as a stockholder of the
Company until you are recorded as the holder of the Shares upon the stock records of the Company. No adjustments are made for dividends
or other rights if the applicable record date occurs before you are recorded as the holder of the Shares.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 27.8pt">&nbsp;</TD></TR>
                                                                                                                   </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">15.</TD><TD STYLE="text-align: justify"><B><U>Adjustments</U></B>. In the event of a stock split, a stock dividend or a similar change in
                                                             the Company stock, the number of Shares covered by these Stock Units may be adjusted (and rounded down to the nearest whole number)
                                                             as appropriate. These Stock Units shall be subject to the terms of the agreement of merger, liquidation or reorganization in the
                                                             event the Company is subject to such corporate activity.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 32.75pt">&nbsp;</TD></TR>
                                                                                                                                 </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 62.95pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">16.</TD><TD STYLE="text-align: justify"><B><U>No Advice Regarding Grant</U></B>. The Company is not providing any tax, legal or financial advice,
nor is the Company making any recommendation regarding the Stock Units, or your acquisition or sale of the underlying Shares. You are
hereby advised to consult your own personal tax, legal and financial advisors regarding the Stock Units and before taking any action related
to the Stock Units.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 34.65pt">&nbsp;</TD></TR>
                             </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 17.95pt">17.</TD><TD STYLE="text-align: justify"><B><U>Not a Contract of Employment</U></B>. By accepting this Award Agreement, you acknowledge and agree that( a) nothing in
                                                                this Award Agreement confers on you any right to continue a service relationship with the Company, nor shall anything in this Award
                                                                Agreement affect in any way your right or the rights of the Company or the Employer to terminate your service at any time, with or
                                                                without cause; and (b) the Company would not have granted this Award to you but for these acknowledgements and agreements.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
                                                                                                                                                                                                    </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 63pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 44.95pt"></TD><TD STYLE="width: 18pt">18.</TD><TD STYLE="text-align: justify"><B><U>Governing Law</U></B>. This Award Agreement, the construction of its terms, and the interpretation
of the rights and duties of the parties hereto are governed by, and subject to, the internal substantive laws but not the choice of law
rules of the State of Delaware. For purposes of litigating any dispute that arises directly or indirectly from the relationship of the
parties evidenced by this Award Agreement, the parties hereby submit to and consent to the exclusive jurisdiction of the State of California
and agree that such litigation shall be conducted only in the courts of San Diego County, California, or the federal courts of the United
States for the Southern District of California, and no other courts, where this Award is made and/or to be performed.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center"><U>EXHIBIT C</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">INSEEGO CORP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 18.95pt 0pt 17.75pt; text-align: center; text-indent: 0in">Inducement
Restricted Stock Unit Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="image_014.gif" ALT="" STYLE="width: 248px; height: 2px"></P>

<P STYLE="margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: 0.5in">Inseego Corp., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), hereby grants Stock Units (the &ldquo;<U>Stock Units</U>&rdquo;) to the individual named below (the
&ldquo;<U>Grantee</U>&rdquo;). The terms and conditions of the Stock Units are set forth in the attached Stock Unit Award Agreement (&ldquo;<U>Award
Agreement</U>&rdquo; or &ldquo;<U>Award</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: 0.5in">&ldquo;<U>Unit</U>&rdquo; or &ldquo;<U>Stock
Unit</U>&rdquo; means the right to receive the equivalent of one (1) share of the Company&rsquo;s common stock (a &ldquo;<U>Share</U>&rdquo;),
in the event the Stock Unit vests and becomes payable pursuant to the terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt; text-indent: 0.5in">This Award constitutes a stand-alone
award, separate and apart from, and outside of, the Inseego Corp. 2018 Omnibus Incentive Compensation Plan (as amended, the &ldquo;<U>Plan</U>&rdquo;)
and shall not constitute an award granted under or pursuant to the Plan. This Award is intended to constitute an &ldquo;employment inducement
grant&rdquo; under Rule 5635(c)(4) of the Nasdaq Listing Rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 27%; border: black 1pt solid; padding-left: 2.95pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name of Recipient</FONT></TD>
    <TD STYLE="width: 73%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 2.95pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Juho Sarvikas</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 2.95pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Number of Stock Units Subject to Award</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 2.95pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">[&#9679;]</FONT><FONT STYLE="font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 2.95pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Purchase Price per Share (if applicable)</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 2.95pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Not applicable.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 2.95pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Date of Grant</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 2.95pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">January [&#9679;], 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 2.95pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Vesting Schedule</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.95pt">Except as otherwise provided in the Award Agreement,
    25% of the Stock Units shall vest on the first anniversary of the Date of Grant (&ldquo;Vesting Commencement Date&rdquo;) and 1/48th of
    the Stock Units shall vest at the end of each of the next 36 calendar months following the Vesting Commencement Date, such that all Stock
    Units subject to the Award shall have vested on the fourth anniversary of the Date of Grant.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: 35.95pt">BY ACCEPTING THIS STOCK UNIT
GRANT, you and the Company agree that the Stock Units are hereby awarded under and governed by the terms and conditions of this
Stock Unit Grant, and the attached Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">INSEEGO CORP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 14%; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: left; width: 33%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 53%; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B><U>Grantee</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 14%; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 33%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 53%; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 3pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Juho Sarvikas</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">___________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">1</FONT>
The number of shares shall be determined by dividing $1,333,000 by the weighted-average closing price of Inseego&rsquo;s common stock
for the period of December 9, 2024 through January 3, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 30.05pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 30.05pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 30.05pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 30.05pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 30.05pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 30.05pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">INSEEGO CORP.</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 40%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 18.8pt 0pt 17.75pt; text-align: center; text-indent: 0in">Inducement
Restricted Stock Unit Award Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 44.95pt"></TD><TD STYLE="width: 18pt">1.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 63pt"><B><U>Other Agreements</U></B>. The Stock Unit Grant and this Award Agreement constitute the entire
understanding between you and the Company regarding these Stock Units. Any prior agreements, commitments or negotiations concerning these
Stock Units are hereby superseded entirely. Notwithstanding the foregoing, to the extent Change in Control and Severance Agreement dated
January [&#9679;], 2025 between you and the Company (the &ldquo;Change in Control Agreement&rdquo;) or any other written employment agreement,
change-in- control agreement, severance agreement or other similar written agreement or arrangement (any such arrangement, an &ldquo;<U>Employment
Arrangement</U>&rdquo;) provides for greater benefits to the Grantee than provided in the Stock Unit Grant or this Award Agreement with
respect to these Stock Units, including with respect to vesting of the Stock Units upon termination of employment or in the event of a
Change in Control, then the terms of the Employment Arrangement with respect to these matters shall supersede the terms of the Stock Unit
Grant and this Award Agreement.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 30.35pt">&nbsp;</TD></TR>
                                         </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">2.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 63pt"><B><U>Termination of Service; Leaves of Absence</U></B>. In the event of a Covered Termination (as
that term is defined in the Change in Control Agreement) all Stock Units shall immediately become vested with respect to that number of
Stock Units that would have vested had you continued employment with the Company for six months following the Termination Date (as that
term is defined in the Change in Control Agreement). In the event of a termination of your service to the Company or any Subsidiary or
Affiliate thereof that is not a Covered Termination, subject to Section 1 above, this Award shall be canceled and become automatically
null and void immediately upon termination of your service to the Company or its Subsidiary or Affiliate for any reason, but only to the
extent you have not become vested, pursuant to the foregoing terms, on or at the time your service to the Company or any Subsidiary or
Affiliate thereof ends. For purposes of the Award, your service is not interrupted or terminated when you go on a leave of absence that
is approved in writing by a duly constituted officer of the Company or any Subsidiary or Affiliate thereof. Your service terminates in
any event when the approved leave ends unless you immediately return to active work at the Company or any Subsidiary or Affiliate thereof.
The Company, in its sole discretion, determines which leaves count for this purpose, as well as the point in time your service terminates
for all purposes under this Agreement.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 30.25pt">&nbsp;</TD></TR>
                                                </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 44.9pt"></TD><TD STYLE="width: 18.05pt">3.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 63pt"><B>Change in Control</B>. In the event of a Change in Control (as that term is defined in the Change
in Control Agreement), one hundred percent (100%) of the Stock Units shall immediately become fully vested.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 38.6pt">&nbsp;</TD></TR>
                                                                                                                     </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">4.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 63pt"><B><U>Satisfaction of Vesting Restrictions</U></B>. No Shares will be issued before you complete the
requirements that are necessary for you to vest in your Stock Units. As soon as practicable after the date on which your Stock Units vest
in whole or in part, the Company will issue to you, free from vesting restrictions (but subject to such legends as the Company determines
to be appropriate), one Share for each vested Stock Unit; <I>provided</I>, <I>however</I>, that, by accepting this Award Agreement, you
authorize the Company to withhold taxes pursuant to Section 8 below.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 28.2pt">&nbsp;</TD></TR>
                                                                              </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">5.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 63pt"><B><U>Investment Purposes</U></B>. By accepting this Award, you represent and warrant to the Company
that any Shares issued to you pursuant to your Stock Units will be for investment for your own account and not with a view to, for resale
in connection with, or with an intent of participating directly or indirectly in, any distribution of such Shares within the meaning of
the U.S. Securities Act of 1933, as amended. You further acknowledge and agree that your ability to sell any Shares issued to you pursuant
to your Stock Units may be limited by applicable securities laws and the Company&rsquo;s Insider Trading Policy then in effect.</TD></TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">6.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 63pt"><B><U>Dividend Equivalents</U></B>. When Shares are delivered to you pursuant to the vesting of your
Stock Units, you shall also be entitled to receive, with respect to each Share issued or withheld by the Company pursuant to <U>Section
7</U>, (a) a number of Shares equal to the per Share stock dividends which were declared and paid to the holders of Shares between the
Date of Grant and the date such Shares are delivered to you, and (b) a number of Shares having a Fair Market Value (on the
date of each cash dividend payment date) equal to any per Share cash dividends that were paid to the holders of Shares based on a record
date falling between the Date of Grant and the date such Shares are delivered to you. To the extent that your service ends before vesting
of all the Stock Units, you will forfeit all dividend equivalents (whether paid in cash or in stock) attributable to all Shares underlying
such unvested Stock Units. </TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 30.75pt">&nbsp;</TD></TR>
                                     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 62.95pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">7.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 63pt"><B><U>Restrictions on Transfer of Award</U></B>. Your rights under this Award Agreement may not be sold,
pledged, or otherwise transferred without the prior written consent of the Board. If you attempt to do any of these things, the Stock
Units will immediately become invalid. You may, however, dispose of these Stock Units in your will. Regardless of any marital property
settlement agreement, the Company is not obligated to honor your spouse&rsquo;s interest in these Stock Units in any way.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 29.9pt">&nbsp;</TD></TR>
                                                                                                                                   </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 44.95pt"></TD><TD STYLE="width: 18pt">8.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 63pt"><B><U>Income Taxes and Deferred Compensation</U></B>. Regardless of any action the Company or your
employer (the &ldquo;<U>Employer</U>&rdquo;) takes with respect to any or all income tax, social insurance, payroll tax, payment on account
or other tax-related items related to the Stock Units and legally applicable to you (&ldquo;<U>Tax-Related Items</U>&rdquo;), you acknowledge
that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility and may exceed the amount
actually withheld by the Company or the Employer. You further acknowledge that the Company and/or the Employer (a) make no representations
or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Stock Units, including the grant
of the Stock Units, the vesting of Stock Units, the settlement of the Stock Units with Shares, the subsequent sale of any Shares acquired
at vesting and the receipt of any dividends; and (b) other than as may be set forth in the Change in Control Agreement or any other Employment
Arrangement, do not commit to structure the terms of the grant or any aspect of the Stock Units to reduce or eliminate your liability
for Tax-Related Items or achieve any particular tax result. You acknowledge that neither the Company nor the Employer shall have any obligation
to indemnify or otherwise hold you harmless from any or all of such Tax-Related Items. Further, if you are subject to tax in more than
one jurisdiction, you acknowledge that the Company and/or the Employer (or former Employer, as applicable) may be required to withhold
or account for Tax-Related Items in more than one jurisdiction.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 63pt">The Board shall have the sole discretion to interpret
the requirements of the U.S. Internal Revenue Code, as amended (the &ldquo;<U>Code</U>&rdquo;) for purposes of this Award Agreement. The
intent of the parties is that payments and benefits under this Award Agreement comply with Section 409A of the Code, and, accordingly,
to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith. To the extent than any provision hereof
must be modified in order to comply with Section 409A of the Code, such modification shall be made in good faith and in compliance with
the terms of the Change in Control Agreement, and shall, to the maximum extent reasonably possible, maintain the original intent and economic
benefit to you without violating the provisions of Section 409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.8pt 0pt 62.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 63pt">Prior to the relevant taxable or tax withholding event,
as applicable, you shall pay, or make adequate arrangements satisfactory to the Company or to the Employer (in their sole discretion)
to satisfy all Tax- Related Items. In this regard, you authorize the Company or the Employer, or their respective agents, at their discretion,
to satisfy the obligations with regard to Tax-Related Items by one or a combination of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 63pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 63pt; text-indent: 0in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>withholding a number of Shares otherwise deliverable to you from time to time equal to the Retained Share Amount (as defined below);
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 45.45pt 0pt 63pt; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 63pt; text-indent: 0in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>withholding from your wages or other cash compensation paid to you by the Company and/or the Employer; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 60.1pt 0pt 63pt; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 63pt; text-indent: 0in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>withholding from proceeds of the sale of Shares acquired upon settlement of the Stock Units, either through a voluntary sale or
through a sale arranged by the Company (on your behalf pursuant to this authorization).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 52.25pt 0pt 63pt; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 52.25pt 0pt 63pt; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 52.25pt 0pt 63pt; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 52.25pt 0pt 63pt; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 52.25pt 0pt 63pt; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 52.25pt 0pt 63pt; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 63pt">To avoid negative accounting treatment, the Company may
withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding
rates. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, you are deemed to have been issued
the full number of Shares subject to the Stock Units, notwithstanding that a number of Shares is retained solely for the purpose of paying
the Tax-Related Items due as a result of any aspect of the Stock Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 62.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 63pt">The &ldquo;<U>Retained Share Amount</U>&rdquo; shall mean a number
of Shares equal to the quotient of the minimum statutory tax withholding obligation of the Company triggered by the vesting of your Award
on the relevant Vesting Date, divided by the Fair Market Value of one Share on the relevant Vesting Date. If the obligation for Tax-Related
Items is satisfied by withholding a number of Shares as described herein, you understand that you will be deemed to have been issued
the full number of Shares subject to the settled Stock Units, notwithstanding that a number of Shares are held back solely for the purpose
of paying the Tax-Related Items due as a result of the settlement of the Stock Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 62.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 63pt">You shall pay to the Company or to the Employer any
amount of Tax-Related Items that the Company or the Employer may be required to withhold as a result of your receipt of Stock Units, the
vesting of Stock Units, or the settlement of vested Stock Units with Shares that cannot be satisfied by the means previously described.
The Company may refuse to deliver Shares to you if you fail to comply with your obligation in connection with the Tax-Related Items.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 63pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">9.</TD><TD STYLE="text-align: justify"><B><U>Notices</U></B>. Any notice or communication required or permitted by any provision of this Award
Agreement to be given to you shall be in writing and shall be delivered electronically, personally, or sent by certified mail, return
receipt requested, addressed to you at the last address that the Company or the Employer had for you on its records. Each party may, from
time to time, by notice to the other party hereto, specify a new address for delivery of notices relating to this Award Agreement. Any
such notice shall be deemed to be given as of the date such notice is personally delivered or properly mailed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 63pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 63pt">The Company may, in its sole discretion, decide to deliver
any documents related to Stock Units by electronic means. You hereby consent to receive such documents by electronic delivery and agree
to participate in an on-line or electronic system established and maintained by the Company or another third party designated by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 63pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">10.</TD><TD STYLE="text-align: justify"><B><U>Binding Effect</U></B>. Except as otherwise provided in this Award Agreement, every covenant,
term, and provision of this Award Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective
heirs, legatees, legal representatives, successors, transferees, and assigns.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 36.15pt">&nbsp;</TD></TR>
                                                                                       </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">11.</TD><TD STYLE="text-align: justify"><B><U>Modifications</U></B>. Subject to Section 7 hereof, this Award Agreement may not be modified
or amended without your prior consent.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 56.15pt">&nbsp;</TD></TR>
                                                </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">12.</TD><TD STYLE="text-align: justify"><B><U>Headings</U></B>. Section and other headings contained in this Award Agreement are for reference
purposes only and are not intended to describe, interpret, define or limit the scope or intent of this Award Agreement or any provision
hereof.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 34.2pt">&nbsp;</TD></TR>
                 </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">13.</TD><TD STYLE="text-align: justify"><B><U>Severability</U></B>. The provisions of this Award Agreement are severable and if any one or more
provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be
binding and enforceable.</TD></TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">14.</TD><TD STYLE="text-align: justify"><B><U>Stockholder Rights</U></B>. You, or your estate or heirs, have no rights as a stockholder of the
Company until you are recorded as the holder of the Shares upon the stock records of the Company. No adjustments are made for dividends
or other rights if the applicable record date occurs before you are recorded as the holder of the Shares.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 27.8pt">&nbsp;</TD></TR>
                                                                                                                   </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt">15.</TD><TD STYLE="text-align: justify"><B><U>Adjustments</U></B>. In the event of a stock split, a stock dividend or a similar change in the
Company stock, the number of Shares covered by these Stock Units may be adjusted (and rounded down to the nearest whole number) as appropriate.
These Stock Units shall be subject to the terms of the agreement of merger, liquidation or reorganization in the event the Company is
subject to such corporate activity.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 32.75pt">&nbsp;</TD></TR>
                                             </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 44.95pt"></TD><TD STYLE="width: 18.05pt">16.</TD><TD STYLE="text-align: justify"><B><U>No Advice Regarding Grant</U></B>. The Company is not providing any tax, legal or financial advice,
nor is the Company making any recommendation regarding the Stock Units, or your acquisition or sale of the underlying Shares. You are
hereby advised to consult your own personal tax, legal and financial advisors regarding the Stock Units and before taking any action related
to the Stock Units.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="padding-right: 34.65pt">&nbsp;</TD></TR>
                             </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 17.95pt">17.</TD><TD STYLE="text-align: justify"><B><U>Not a Contract of Employment</U></B>. By accepting this Award Agreement, you acknowledge and agree that (a) nothing in
                                                                this Award Agreement confers on you any right to continue a service relationship with the Company, nor shall anything in this Award
                                                                Agreement affect in any way your right or the rights of the Company or the Employer to terminate your service at any time, with or
                                                                without cause; and (b) the Company would not have granted this Award to you but for these acknowledgements and agreements.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
                                                                                                                                                                                                    </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 63pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 44.95pt"></TD><TD STYLE="width: 18pt">18.</TD><TD STYLE="text-align: justify"><B><U>Governing Law</U></B>. This Award Agreement, the construction of its terms, and the interpretation
of the rights and duties of the parties hereto are governed by, and subject to, the internal substantive laws but not the choice of law
rules of the State of Delaware. For purposes of litigating any dispute that arises directly or indirectly from the relationship of the
parties evidenced by this Award Agreement, the parties hereby submit to and consent to the exclusive jurisdiction of the State of California
and agree that such litigation shall be conducted only in the courts of San Diego County, California, or the federal courts of the United
States for the Southern District of California, and no other courts, where this Award is made and/or to be performed.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.95pt; text-align: center"><U>EXHIBIT D</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">INSEEGO CORP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 18.8pt 0pt 17.75pt; text-align: center"><B>INDUCEMENT NONSTATUTORY STOCK
OPTION GRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.25pt 0pt 27pt; text-indent: 0.5in">Inseego Corp., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), hereby grants options (the &ldquo;<U>Options</U>&rdquo;) to purchase shares of its common stock (the
&ldquo;<U>Shares</U>&rdquo;) to the individual named below (the &ldquo;<U>Optionee</U>&rdquo;). The terms and conditions of the Options
are set forth in the attached agreement (the &ldquo;<U>Award Agreement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt; text-indent: 0.5in">These Options are made and granted
as a stand-alone award, separate and apart from, and outside of, the Inseego Corp. 2018 Omnibus Incentive Compensation Plan (as amended,
the &ldquo;<U>Plan</U>&rdquo;) and shall not constitute an award granted under or pursuant to the Plan. The grant of these Options is
intended to constitute an &ldquo;employment inducement grant&rdquo; under Rule 5635(c)(4) of the Nasdaq Listing Rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 27%; border: black 1pt solid; padding-left: 2.95pt"><FONT STYLE="font-size: 10pt">Name of Optionee</FONT></TD>
    <TD STYLE="width: 73%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 2.95pt"><FONT STYLE="font-size: 10pt">Juho Sarvikas</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 2.95pt"><FONT STYLE="font-size: 10pt">Number of Options Granted</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 2.95pt"><FONT STYLE="font-size: 10pt">[&#9679;]</FONT><FONT STYLE="font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 2.95pt"><FONT STYLE="font-size: 10pt">Option Price per Share</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 2.95pt"><FONT STYLE="font-size: 10pt">$[&#9679;]</FONT><FONT STYLE="font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 2.95pt"><FONT STYLE="font-size: 10pt">Date of Option Grant</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 2.95pt"><FONT STYLE="font-size: 10pt">January [&#9679;], 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 2.95pt"><FONT STYLE="font-size: 10pt">Option Expiration Date</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 2.95pt"><FONT STYLE="font-size: 10pt">January [&#9679;], 2035</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 2.95pt"><FONT STYLE="font-size: 10pt">Time-Vesting Schedule</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt">4 Year vesting:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&bull; 25% of the Options shall vest on the first anniversary of the Grant Date</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&bull;1/48th of the Options shall vest per month thereafter starting on the 13-month anniversary of the Grant Date</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 2.95pt"><FONT STYLE="font-size: 10pt">Conditions to Exercisability</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 2.95pt"><FONT STYLE="font-size: 10pt">To become exercisable, in addition to time-based vesting the closing price per share of the Company&rsquo;s common stock (INSG) must have exceeded the Exercise Price for 20 trading days within the 30-trading day period prior to exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 27pt; text-indent: 35.95pt"><B><I>By accepting this Option
Grant, the Optionee hereby agrees to all the terms and conditions set forth in this Option Grant and the attached Award Agreement.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt; width: 14%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font-size: 10pt; width: 33%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 53%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Optionee:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 14%; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 33%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 53%; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 3pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Juho Sarvikas</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.2pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">___________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 144.7pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">1</FONT>
There will be for option documents - one for each tranche of options, as follows:</P>

<P STYLE="margin: 0pt 144.7pt 0pt 20pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><U>Shares - Exercise Price</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 144.7pt 0pt 20pt; text-align: left">200,000 - Grant date FMV*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 144.7pt 0pt 20pt; text-align: left">210,000 - Grant date FMV*
+$5</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 144.7pt 0pt 20pt; text-align: left">215,000 - Grant date FMV* + $10</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 144.7pt 0pt 20pt; text-align: left">225,000 - Grant date FMV* +$15</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 30.05pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">2</FONT> FMV for determining
exercise price shall be based on the weighted-average closing price of Inseego&rsquo;s common stock for the period of December 9, 2024
through January 3, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 30.05pt 0pt 26.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 211.25pt 0pt 210.25pt; text-align: center"><B>INSEEGO CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 18.8pt 0pt 17.75pt; text-align: center"><B>INDUCEMENT NONSTATUTORY STOCK
OPTION AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 18%; padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Other Agreements</B></FONT></TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify; width: 82%"><FONT STYLE="font-size: 10pt">The Option Grant and this Award Agreement constitute the entire understanding between you and the Company regarding these Options. Any prior agreements, commitments or negotiations concerning these Options are hereby superseded entirely. Notwithstanding the foregoing, to the extent the Change in Control and Severance Agreement dated January [&#9679;], 2025 between you and the Company (the &ldquo;Change in Control Agreement&rdquo;) or any other written employment agreement, change-in-control agreement, severance agreement or other similar written agreement or arrangement (any such arrangement, an &ldquo;<U>Employment Arrangement</U>&rdquo;) provides for greater benefits to the Optionee than provided in the Option Grant or this Award Agreement with respect to these Options, including with respect to (a) vesting of the Options upon termination of employment or in the event of a Change in Control, or (b) exercisability of the Options following termination of employment, then the terms of the Employment Arrangement with respect to these matters shall supersede the terms of the Option Grant and this Award Agreement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-left: 3.35pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Nonstatutory Stock Option</B></FONT></TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">These Options are not intended to be Incentive Stock Options under section 422 of the U.S. Internal Revenue Code, as amended (the &ldquo;<U>Code</U>&rdquo;) and will be interpreted accordingly.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-left: 3.35pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Vesting</B></FONT></TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">These Options are exercisable only before they expire and then only with respect to those that are vested. These Options will vest according to the Time-Vesting Schedule on the attached cover sheet.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-left: 3.35pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Conditions to Exercisability</B></FONT></TD>
    <TD>
    <P STYLE="padding-left: 3.35pt; text-align: justify">To become exercisable, in addition to time-based vesting the closing price per
share of the Company&rsquo;s common stock (INSG) must have exceeded the Exercise Price for 20 days within a 30-trading day period prior
to exercise.</P>
    <P STYLE="padding-left: 3.35pt; text-align: justify">Except as otherwise provided in this Award Agreement, any vested and exercisable portion of this Option may be exercised,
in whole or in part, with respect to such Shares at any time on or after the Date of Grant, or such earlier date and with respect to
such number of Shares as may apply pursuant to the terms of the Change in Control Agreement, or any other agreement between the Optionee
and the Company providing for accelerated vesting in certain events, or, if earlier, upon consummation of a Change in Control as provided
(and defined in) the Change in Control Agreement.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Term</B></FONT></TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">These Options will expire in any event at the close of business at Company headquarters on the 10th anniversary of the Vesting Commencement Date, as shown on the cover sheet. These Options will expire earlier if your service terminates, as described below.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-left: 3.35pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Change in Control</B></FONT></TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">In the event of a Change in Control (as that term is defined in the Change in Control Agreement), notwithstanding any provision of this Award Agreement to the contrary, these Options shall become immediately vested with respect to 100% of the Shares subject to the Options, and shall be exercisable to the extent that the value received by the Company&rsquo;s stockholders in connection with the Change in Control exceeds the Option Price. To the extent practicable, such acceleration of vesting and exercisability shall occur in a manner and at a time which allows you the ability to participate in the Change in Control with respect to the shares of common stock received.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt; width: 18%"><FONT STYLE="font-size: 10pt"><B>Covered Termination</B></FONT></TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify; width: 82%"><FONT STYLE="font-size: 10pt">If your service terminates because of a Covered Termination, then, subject to Optionee&rsquo;s compliance with the terms of the applicable Employment Arrangement, (i) the time-based vesting of the Options shall be accelerated with respect to that number of Shares that would have vested had you continued employment with the Company for six months following the Termination Date and (ii) these Options will expire at the close of business at Company headquarters on the date twelve (12) months after the Termination Date. For purposes of this Award Agreement, &ldquo;Covered Termination&rdquo; and &ldquo;Termination Date&rdquo; shall have the respective meanings set forth in the Change in Control Agreement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Termination for Cause</B></FONT></TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">If your service is terminated for Cause, then immediately upon such event you automatically forfeit all rights to these Options and they shall immediately expire. For purposes of this Award Agreement, &ldquo;<U>Cause</U>&rdquo; shall have the meaning set forth in in the Change in Control Agreement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 18%; padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Death</B></FONT></TD>
    <TD STYLE="width: 82%">
    <P STYLE="padding-left: 3.35pt; text-align: justify">If your service terminates because of your death, then, except as otherwise provided in an
    Employment Arrangement, these Options will expire at the close of business at Company headquarters on the date twelve (12) months
    after the date of death. At any time during that twelve 12) month period, your estate or heirs may exercise those Options which were
    vested as of the date of your death.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Other Termination</B></FONT></TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">If your service terminates for any reason, other than death, a Covered Termination, or Cause, then these Options will expire at the close of business at Company headquarters on the 90th calendar day after your service termination date.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Leave of Absence</B></FONT></TD>
    <TD>
    <P STYLE="padding-left: 3.35pt; text-align: justify">For purposes of these Options, your service is not interrupted or terminated
when you go on a leave of absence that was approved in writing by a duly constituted officer of the Company or any Subsidiary or Affiliate
thereof. Your service terminates in any event when the approved leave ends unless you immediately return to active work at the Company
or any Subsidiary or Affiliate thereof.</P>
    <P STYLE="padding-left: 3.35pt; text-align: justify">The Company, in its sole discretion, determines which leaves count for this purpose, as well as
the point in time your service terminates for all purposes under this Agreement.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Method of Exercise</B></FONT></TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">When you wish to exercise any of these Options, you must provide written notice to the Company, or use such other method of exercise as may be specified by the Company, including exercise by electronic means on the web site of the Company&rsquo;s third-party equity plan administrator, which will specify how many Options you wish to exercise. If someone else wants to exercise these Options after your death, that person must prove to the Company&rsquo;s satisfaction that he or she is entitled to do so.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Form of Payment</B></FONT></TD>
    <TD>
    <P STYLE="padding-left: 3.35pt; text-align: justify">When you exercise Options, you must remit payment of
    the Option Price for the Shares you are purchasing at that time and any Tax-Related Items (as defined below). Payment may be made in one
    or a combination of the following forms:</P>
    <P STYLE="padding-left: 3.35pt">Cash, your personal check, a cashier&rsquo;s check or a money order.</P>
    <P STYLE="padding-left: 3.35pt; text-align: justify">By delivery (on a form or by
electronic means prescribed by the Company) of an irrevocable direction to a securities broker to sell Shares and to deliver all or part
of the sale proceeds to the Company in payment of the aggregate Option Price and any Tax-Related Items.</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt; width: 18%">&nbsp;</TD>
    <TD STYLE="width: 82%">&nbsp;</TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 18%; padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Withholding Taxes</B></FONT></TD>
    <TD STYLE="width: 82%">
    <P STYLE="padding-left: 3.35pt; text-align: justify">Regardless of any action the Company or your employer
    (the &ldquo;Employer&rdquo;) takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related
    items related to the Option Grant and legally applicable to you (&ldquo;Tax-Related Items&rdquo;), you acknowledge that the ultimate liability
    for all Tax-Related Items is and remains your responsibility and may exceed the amount actually withheld by the Company or the Employer.
    You further acknowledge that the Company and/or the Employer (a) make no representations or undertakings regarding the treatment of any
    Tax-Related Items in connection with any aspect of the Options, including, but not limited to, the grant, vesting or exercise of the Options,
    the subsequent sale of Shares acquired pursuant to such exercise and the receipt of any dividends; and (b) except as may be set forth
    in the Change in Control Agreement or any other Employment Arrangement, do not commit to and are under no obligation to structure the
    terms of the grant or any aspect of the Options to reduce or eliminate your liability for Tax-Related Items or achieve any particular
    tax result. You acknowledge that neither the Company nor the Employer shall have any obligation to indemnify or otherwise hold you harmless
    from any or all of such Tax-Related Items. Further, if you are subject to tax in more than one jurisdiction, you acknowledge that the
    Company and/or the Employer (or former Employer, as applicable) may be required to withhold or account for Tax-Related Items in more than
    one jurisdiction.</P>
    <P STYLE="padding-left: 3.35pt"></P>
    <P STYLE="padding-left: 3.35pt; text-align: justify">Prior to any relevant taxable or tax withholding event, as applicable, you will pay or make adequate
arrangements satisfactory to the Company and/or the Employer to satisfy all Tax-Related Items. In this regard, you authorize the Company
and/or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items
by one or a combination of the following:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.75pt 0pt 33.95pt; text-indent: -9.05pt">1. withholding from your wages
    or other cash compensation paid to you by the Company and/or the Employer; or</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.95pt; text-indent: -9.05pt">2. withholding from proceeds
    of the sale of Shares acquired at exercise, either through a voluntary sale or through a sale arranged by the Company (on your behalf
    pursuant to this authorization); or</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.55pt 0pt 33.95pt; text-indent: -9.05pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.95pt; text-indent: -9.05pt">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
    </FONT>withholding in Shares to be issued at exercise.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
    <P STYLE="padding-left: 3.35pt; text-align: justify">To avoid negative accounting treatment, the Company may withhold or account
for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates. If the obligation
for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, you are deemed to have been issued the full number of
Shares subject to the Options exercised, notwithstanding that a number of Shares is retained solely for the purpose of paying the Tax-Related
Items due as a result of any aspect of the Option Grant.</P>
    <P STYLE="padding-left: 3.35pt; text-align: justify">Finally, you will pay to the Company or the Employer any amount of Tax-Related
Items that the Company or the Employer may be required to withhold or account for as a result of the Option Grant that cannot be satisfied
by the means previously described. The Company may refuse to issue or deliver Shares or the proceeds from the sale of Shares if you fail
to comply with your obligations in connection with the Tax-Related Items.</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt; width: 18%"><FONT STYLE="font-size: 10pt"><B>Transfer of Options</B></FONT></TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify; width: 82%"><FONT STYLE="font-size: 10pt">Prior to your death, only you may exercise these Options, or in the case of legal incapacity, your guardian or legal representative may act on your behalf. You cannot transfer or assign these Options. For instance, you may not sell the Options themselves or use them as security for a loan. If you attempt to do any of these things, the Options will immediately become invalid. You may, however, dispose of these Options in your will. Regardless of any marital property settlement agreement, the Company is not obligated to honor your spouse&rsquo;s interest in these Options in any way.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Retention Rights</B></FONT></TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">These Options or this Award Agreement do not give you the right to be retained or to continue to be retained by the Company or any Subsidiary or Affiliate thereof in any employment or other capacity. The Company or any Subsidiary or Affiliate thereof reserves the right to terminate your service at any time and for any reason.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Stockholder Rights</B></FONT></TD>
    <TD>
    <P STYLE="padding-left: 3.35pt; text-align: justify">You, or your estate or heirs, have no rights as a stockholder of the Company
    with respect to the Options until you are recorded as the holder of the Shares upon the stock records of the Company. No adjustments
    are made for dividends or other rights if the applicable record date occurs before you are recorded as the holder of the Shares.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 18%; padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Adjustments</B></FONT></TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify; width: 82%"><FONT STYLE="font-size: 10pt">In the event of a stock split, a stock dividend or a similar change in the Company stock, the number of Shares covered by these Options and the Option Price may be adjusted (and rounded down to the nearest whole number) as appropriate. These Options shall be subject to the terms of the agreement of merger, liquidation or reorganization in the event the Company is subject to such corporate activity.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>No Advice Regarding Grant</B></FONT></TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Option Grant, or your acquisition or sale of the underlying Shares. You are hereby advised to consult your own personal tax, legal and financial advisors regarding the Option Grant and before taking any action related to the Option Grant.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Not a Contract of Employment</B></FONT></TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">By accepting this Award Agreement, you acknowledge and agree that (a) nothing in this Award Agreement confers on you any right to continue a service relationship with the Company, nor shall anything in this Award Agreement affect in any way your right or the rights of the Company or the Employer to terminate your service at any time, with or without cause; and (b) the Company would not have granted this Option to you but for these acknowledgments and agreements.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Applicable Law</B></FONT></TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">The Option grant and the provisions of this Award Agreement are governed by, and subject to, the internal substantive laws but not the choice of law rules of the State of Delaware. For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties evidenced by this grant or this Award Agreement, the parties hereby submit to and consent to the exclusive jurisdiction of the State of California, and agree that such litigation shall be conducted only in the courts of San Diego County, California, or the federal courts of the United States for the Southern District of California, and no other courts, where this grant is made and/or to be performed.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Electronic Delivery</B></FONT></TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">The Company may, in its sole discretion, decide to deliver any documents related to the Option Grant by electronic means. You hereby consent to receive such documents by electronic delivery and to agree to participate in an on-line or electronic system established and maintained by the Company or another third party designated by the Company.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-left: 3.35pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Severability</B></FONT></TD>
    <TD>
    <P STYLE="padding-left: 3.35pt; text-align: justify">The provisions of this Award Agreement are severable and if any one or more
    provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless
    be binding and enforceable.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<P STYLE="margin: 0"><B></B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>inseego_ex9901.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B><IMG SRC="image_002.jpg" ALT=""></B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B></B></P>

<DIV STYLE="padding: 0in 0in 7pt; border-bottom-width: 0in; border-bottom-color: black"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-size: 14pt; color: #00C2FF"><B>Juho
                                            Sarvikas, Former President of Qualcomm North America,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-size: 14pt; color: #00C2FF"><B>Appointed Chief Executive Officer of
                                            Inseego</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-size: 12pt"><I>Sarvikas
to Lead Inseego in Its Next Phase of Growth Following the Company&rsquo;s Successful Overhaul of its Capital Structure</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-size: 12pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-size: 12pt"><I>Company
Also Adds Brian Miller, One of Inseego&rsquo;s Largest Stockholders and Noteholders, to its Board of Directors</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><I>&nbsp;</I></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SAN DIEGO &ndash; January 6, 2025 &ndash; </B>Inseego Corp. (Nasdaq:
INSG) (&ldquo;Inseego&rdquo; or the &ldquo;Company&rdquo;), a technology leader in 5G mobile and fixed wireless solutions for mobile network
operators, Fortune 500 enterprises, and SMBs, today announced the appointment of Juho Sarvikas as Chief Executive Officer and a Director
on the Company&rsquo;s Board of Directors, effective immediately.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Juho&rsquo;s exceptional leadership in the wireless industry,
proven track record of operational excellence, and extensive industry relationships make him the perfect choice to lead Inseego&rsquo;s
continued evolution as CEO,&rdquo; said Phil Brace, Executive Chairman of Inseego&rsquo;s Board of Directors. &ldquo;His deep expertise
and strategic vision will enhance our position in the wireless marketplace and drive the Company&rsquo;s next phase of growth and innovation.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sarvikas joins Inseego from Qualcomm, where he served as President
of Qualcomm North America since 2021, and where he led the company&rsquo;s diversification strategy for the region with particular focus
on go-to-market. Prior to Qualcomm, Sarvikas served as Chief Product Officer of HMD Global from 2016 to 2021, where he was a founding
member and spearheaded the relaunch of Nokia phones, growing the company to a multi-billion dollar topline. Before joining HMD Global,
Sarvikas held various leadership roles across sales and product at Nokia and Microsoft.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Inseego has achieved extraordinary progress on several important
fronts over the past year and is now well-positioned to capitalize on an expanding market opportunity,&rdquo; said Sarvikas. &ldquo;I
am honored to join this talented team at such a pivotal moment and look forward to building on Inseego&rsquo;s strong technology and product
leadership. I&rsquo;m excited to drive Inseego forward as the partner of choice in the wireless ecosystem, bringing first-to-market innovation
and delivering meaningful value for shareholders.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition to Sarvikas&rsquo; appointment, Brian Miller has re-joined
Inseego&rsquo;s Board of Directors. Miller is Chief Investment Officer of North Sound Partners and has been invested in Inseego since
2018. North Sound is one of Inseego&rsquo;s largest stockholders and noteholders, beneficially owning 19.9% of the Company&rsquo;s common
stock (as calculated under Securities and Exchange Commission rules) and 53% of the principal amount of the Company&rsquo;s senior secured
notes due in 2029. North Sound specializes in making direct investments in both public and private growth companies and collaborates with
their management teams to create shareholder value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Miller previously served on Inseego&rsquo;s Board from 2018 to 2021.
Prior to founding North Sound, he spent more than 20 years at Elliott Management, a New York-based hedge fund, where he was an equity
partner, Chief Trading Officer, and a member of the management committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Inseego&rsquo;s transformation over the past year has been remarkable
and established a strong foundation for growth and sustained profitability,&rdquo; said Miller. &ldquo;With a clean balance sheet and
positive cash flow visibility, Inseego is well-positioned to pursue meaningful organic and inorganic growth opportunities. As both a committed
investor and board member, I am eager to contribute to Inseego&rsquo;s next phase of value creation.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As part of his appointment as CEO, Inseego will issue inducement
awards of 855,000 stock options, 124,347 time-based restricted share units (&ldquo;RSUs&rdquo;), and 167,910 performance share units
(&ldquo;PSUs&rdquo;) to Sarvikas (together, the &ldquo;Inducement Awards&rdquo;). The options will have a ten-year term and exercise
prices ranging from $10.72 to $25.72. The options will vest over a four-year period, with 25% of the options vesting on the first
anniversary of the date of grant and the remainder vesting in equal monthly installments over the three years thereafter. The RSUs
vest over four years, subject to each employee&rsquo;s continuous employment on each vesting date. The PSUs provide for cliff
vesting at the end of the three-year performance period, with the number of shares to be issued based on achievement of defined
performance-based vesting conditions over the three-year performance period and will be subject to the employee&rsquo;s continuous
employment through the vesting date. Other terms of the options, RSUs and PSUs are as determined by the Compensation Committee and
are as set forth in the applicable award agreements covering each grant. The Inducement Awards were approved by the independent
compensation committee of Inseego&rsquo;s board of directors in accordance with Nasdaq Marketplace Rule 5635(c)(4).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company also announced today that there was no change to its financial
guidance provided for the fourth quarter of 2024, ended December 31, 2024 (which was issued on November 12, 2024). The Company plans to
announce its fourth quarter and full-year 2024 financial results in mid-February, with details of the accompanying conference call to
be shared closer to the date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Inseego Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Inseego Corp. (Nasdaq: INSG) is the industry leader in 5G Enterprise
cloud WAN solutions, with millions of end customers and thousands of enterprise and SMB customers on its 4G, 5G, and cloud platforms.
Inseego's 5G Edge Cloud combines the industry's best 5G technology, rich cloud networking features, and intelligent edge applications.
Inseego powers new business experiences by connecting distributed sites and workforces, securing enterprise data, and improving business
outcomes with intelligent operational visibility---all over a 5G network. For more information on Inseego, visit www.inseego.com. #Putting5GtoWork</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Cautionary Note Regarding Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Some of the information presented in this news release may constitute
forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In this context, forward-looking
statements often address expected future business and financial performance and often contain words such as &ldquo;may,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;project,&rdquo;
&ldquo;will&rdquo; and similar words and phrases indicating future results. The information presented in this news release related to
our future business outlook, the future demand for our products, and other statements that are not purely historical facts are forward-looking.
These forward-looking statements are based on management&rsquo;s current expectations, assumptions, estimates, and projections. They are
subject to significant risks and uncertainties that could cause results to differ materially from those anticipated in such forward-looking
statements. We, therefore, cannot guarantee future results, performance, or achievements. Actual results could differ materially from
our expectations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Factors that could cause actual results to differ materially from the
Company&rsquo;s expectations include: (1) the Company&rsquo;s dependence on a small number of customers for a substantial portion of our
revenues; (2) the future demand for wireless broadband access to data and asset management software and services and our ability to accurately
forecast; (3) the growth of wireless wide-area networking and asset management software and services; (4) customer and end-user acceptance
of the Company&rsquo;s current product and service offerings and market demand for the Company&rsquo;s anticipated new product and service
offerings; (5) our ability to develop sales channels and to onboard channel partners; (6) increased competition and pricing pressure from
participants in the markets in which the Company is engaged; (7) dependence on third-party manufacturers and key component suppliers worldwide;
(8) the impact of fluctuations of foreign currency exchange rates; (9) the impact of supply chain challenges on our ability to source
components and manufacture our products; (10) unexpected liabilities or expenses; (11) the Company&rsquo;s ability to introduce new products
and services in a timely manner, including the ability to develop and launch 5G products at the speed and functionality required by our
customers; (12) litigation, regulatory and IP developments related to our products or components of our products; (13) the Company&rsquo;s
ability to raise additional financing when the Company requires capital for operations or to satisfy corporate obligations; (14) the Company&rsquo;s
ability to execute its plans and expectations relating to acquisitions, divestitures, strategic relationships, software and hardware development,
personnel matters, and cost containment initiatives; (15) the global semiconductor shortage and any related price increases or supply
chain disruptions, (16) the potential impact of COVID-19 or other global public health emergencies on the business, (17) the impact of
high rates of inflation and rising interest rates, (18) the impact of import tariffs on our materials and products, and (19) the impact
of geopolitical instability on our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">These factors, as well as other factors set forth as risk factors or
otherwise described in the reports filed by the Company with the SEC (available at www.sec.gov), could cause results to differ materially
from those expressed in the Company&rsquo;s forward-looking statements. The Company assumes no obligation to update publicly any forward-looking
statements, even if new information becomes available or other events occur in the future, except as otherwise required under applicable
law and our ongoing reporting obligations under the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&copy;2025. Inseego Corp. All rights reserved. Inseego is a trademark
of Inseego Corp. Other Company, product, or service names mentioned herein are the trademarks of their respective owners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="image_017.gif" ALT="" STYLE="height: 1px; width: 1px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="background-color: white"><B>Investor
Relations Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="background-color: white"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Matt Glover and Alec Wilson, Gateway Group</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">IR@inseego.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">(949) 574-3860</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="background-color: white"><B>Media
Relations Contact: </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Jodi Ellis, Inseego Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">PR@inseego.com</P>
<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B></B></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>insg-20250106.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOaqBaaPty552SYkxvmR5famKvy8nKGAbhCLit6PmkSoC -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:INSG="http://inseego.com/20250106" elementFormDefault="qualified" targetNamespace="http://inseego.com/20250106">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://inseego.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="insg-20250106_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="insg-20250106_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>insg-20250106_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>insg-20250106_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://inseego.com/role/Cover" xlink:href="insg-20250106.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://inseego.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  N *H# 2(  A$! Q$!_\0
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M.M-*L8[.RA6*",851_,^IKG_ !)X#TSQ#/\ :RSVMYWFB'WOJ._Z5U5% 'G
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F-\//YZEKB[_Y[2#[O^Z.U=-116-2I.I+FF[LZ*5*%*/+35D?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  N *H# 2(  A$! Q$!_\0
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M.M-*L8[.RA6*",851_,^IKG_ !)X#TSQ#/\ :RSVMYWFB'WOJ._Z5U5% 'G
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F-\//YZEKB[_Y[2#[O^Z.U=-116-2I.I+FF[LZ*5*%*/+35D?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_014.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_014.gif
M1TE&.#EA^  " '< ,2'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "'Y
H! $     +    0#X  $ @         (.1(ZIR^T/HYRTVHNSK@4 .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_017.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_017.gif
K1TE&.#EA 0 ! (   ,# P    "'Y! $     +      !  $   ("1 $ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45598788748016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jan. 06, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan.  06,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38358<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INSEEGO CORP.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001022652<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-3377646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9710 Scranton Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">812-3400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
                                            Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">INSG<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M^58[<S0HV?Q4\AOR/_X"H\*7"Y(R3;8LSCGYSKN"T86DX)ILPS2ZQ:I?4+S
M+S2+;*H&;\E2U29J@P ,>@\82=4<*%[(W[U+IJ_AALDU/SEY-@@]CH.[\:\8
M4]45Z%E=89IPO;9>>@ %L['5)F6R/@]PP9.YZ1Z]$MN?%[XP>\>,Q'P%0MY5
M#W3U_HU]OS J+=Z2E\K .W=QN.$,GAM[ 7R_4LJ\+^R+=_F[R>@?4$L#!!0
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ )S F6IE<G",0!@  G"<  !,
M             ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M"  G,"9:SEMR.5\$  !#$0  &               @($-"   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ )S F6I^@&_"Q @  X@P   T
M             ( !H@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  G,"9:
MEXJ[',     3 @  "P              @ %^#P  7W)E;',O+G)E;'-02P$"
M% ,4    "  G,"9:JL0B%C,!   B @  #P              @ %G$   >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ )S F6B0>FZ*M    ^ $  !H
M         ( !QQ$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ )S F6F60>9(9 0  SP,  !,              ( !K!(  %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ]A,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="inseego_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inseego.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="inseego_8k.htm">inseego_8k.htm</File>
    <File>insg-20250106.xsd</File>
    <File>insg-20250106_lab.xml</File>
    <File>insg-20250106_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "inseego_8k.htm": {
   "nsprefix": "INSG",
   "nsuri": "http://inseego.com/20250106",
   "dts": {
    "inline": {
     "local": [
      "inseego_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "insg-20250106.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "insg-20250106_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "insg-20250106_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://inseego.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-01-06",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inseego_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-01-06",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "inseego_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://inseego.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001683168-25-000095-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-25-000095-xbrl.zip
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M'FAOE@_&@#.E5Z2<:"09#UAG)$R,82UFNT8+0@QXY>7O[@9E0(2\ZPAXY#A
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M+(0O L= 0_(X'43#*3)P/H[(=] W@'94.*W^#I(16#80'1SP'O6+,T7;$_[
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MSY:V^KL\;S_*C;WEW=CUVL5W=64_!)GYBRYMW]SA&..L>"JJ9UWE=*P8)N!
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M<9@?LK20L2%-'@R'N"9(,(>XF,1,=.1K'@$G#3/RO2^N^JM? ?/17#6#VS5
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M-=!I8F)@%- YV](U'W-</1:/6QN&R!/\?3#!7M5%]1?>7C98NA%#Y2(MC!#
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MD:;$.QTO T.RUFM=J9;]E4&57IZ;VDJ.99"M6JQ:K.%KE'$#FC09%%;LG$2
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MS1S<?'O$0IR3V,?V.EA<)68/A:F&.9EE7,1*WB,^"Z$><D+05AG(I5'?5 '
M*.^PR%.$XM,01A%&S0_*/AN?<9\T9$VGDMQA ?2D]*E-6T52N"2XO-FG<I$Q
ML->DXS]8+GG+.%J'HU1*JK\-KRR+O 1:'$0, PH; V>["'5>.>DL?6-;K96Q
M:/:95',@,?V3#C[^<5:(7].F&BU.MWUV78[R0]WWAP\[<H;LP =QYO05(9V
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M'+P^[7;?=4_.%WF=^F+S/:SRX?N3L^.C[NG!^?'[DP>XSU]A5=\4 ];V5E/
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M/8ZK<F[[@\:E"?MHC@1MX$("' =E1@RF$KQP3!X_(H*TA^&?%-MG$6J((VB
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MKN/=P*[(O>WME=YJIYZ'L#!GY)R37;":ZM0)NJ[7 [P,!Q%H0R5&X;D%%49
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M12,5+S\,AHB 1F)TXW07SHR#9VAO.?8C11_2^((4MF@[?;RC->&;YZ+D04#
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M!BG4:C\ BCA*=:4L,3ZSKAIR3(DM7<6TWOTT*B1H.8F2@?Y:W5 EN+CN$O.
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M <B07LEG9/Z.41)2ADK>[2RX*D^S5Y%Q_BP06GZ&9 MF'YS-PA-"8+IT2OL
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MTJ4"H\Q-:<LE2^%JM6QUIDS_7)KKH9/ZE[WPX. @W-W=59_EBC $\>!YA$0
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M[G).:]AZXU#Z8TL#WP*;V^15PF6(.)2^5'Q6+5BGJ3!$E@;*O?!04R(S:K:
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MEL(L..R-#@>'WQ/)3:F:XCY9"Y,5VV Z03) WB".P1%V>04H8B'S$ #//B8
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MG+U0,P6\$4ROI4FR?%V6ZF%K;+WR#<I!LLX=(OC<0\$-F;B./U91<I#C+%0
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MWT!7EQ\_(/7K?#)-=$L@<-OHACEFGWKL CWB$-KH#BAP+!F_0*\XB+6%W9(
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MJ9I!I3'X*GAGD./;"P,:8-QDZ(@("+T!-J$;#GDDRD,_H"(8U:(]G9^EARR
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M9V]?97@Q,# Q+FAT;5!+ 0(4 Q0    ( "<P)EH2?&P-<Q0  -E)   2
M          "  4S>  !I;G-E96=O7V5X.3DP,2YH=&U02P$"% ,4    "  G
M,"9:D921R2D#  #@"P  $0              @ 'O\@  :6YS9RTR,#(U,#$P
M-BYX<V102P$"% ,4    "  G,"9:K9Q>\/X*  " A@  %0
M@ %']@  :6YS9RTR,#(U,#$P-E]L86(N>&UL4$L! A0#%     @ )S F6INI
M_\;;!P  [EX  !4              ( !> $! &EN<V<M,C R-3 Q,#9?<')E
:+GAM;%!+!08     !@ & ($!  "&"0$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>inseego_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="insg-20250106.xsd" xlink:type="simple"/>
    <context id="AsOf2025-01-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022652</identifier>
        </entity>
        <period>
            <startDate>2025-01-06</startDate>
            <endDate>2025-01-06</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-01-06" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-01-06" id="Fact000004">0001022652</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-01-06" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-01-06" id="Fact000010">2025-01-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-01-06" id="Fact000011">INSEEGO CORP.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-01-06" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-01-06" id="Fact000013">001-38358</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-01-06" id="Fact000014">81-3377646</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-01-06" id="Fact000015">9710 Scranton Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-01-06" id="Fact000016">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-01-06" id="Fact000017">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-01-06" id="Fact000018">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-01-06" id="Fact000019">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-01-06" id="Fact000020">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-01-06" id="Fact000021">812-3400</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-01-06" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-01-06" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-01-06" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-01-06" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-01-06" id="Fact000026">Common                                             Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-01-06" id="Fact000027">INSG</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-01-06" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-01-06" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
